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ABSTRACT 
Title  
Awareness, knowledge and experiences of women regarding cervical cancer in rural Kwa-
Zulu-Natal, South Africa. 
Background 
Cervical cancer has been identified as the second most common cancer in women and 
contributes to the high mortality rate in women. Among all cancers in women, cervical 
cancer  is rated the second most common cancer in women worldwide. In poorly 
resourced settings, access to services offering cervical screening is still a challenge and it 
is estimated that more than 50% of women in developing countries have never had a 
single screening test for cervical abnormalities. 
Purpose 
The purpose of this study was to assess women’s awareness, attitudes and experiences 
regarding cervical smear testing and for cervical cancer in rural KwaZulu-Natal and to 
better understand factors influencing access to and utilization of cervical cancer screening 
services by rural women.  
Methods 
The method employed was a descriptive study using a questionnaire to collect quantitative 
data. The sample consisted of 69 women aged 30 years and above, was taken from women 
who were enrolled in the on-going Microbicide Clinical Trial and attending follow-up 
clinic visits between July and August 2009. The primary outcome measure for the 
analyses was who has been screened for cervical cancer and this was assessed from the 
previous history reports of the women. The secondary outcome measure was to investigate 
knowledge and perceptions regarding cervical cancer and screening. Socio-demographic 
factors associated with having been screened were also explored.  
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Results 
Out of 69 women, only N=13 (18.8%) reported ever screening for cervical cancer. More 
than half of women who had never screened reported lack of information as a barrier to 
screening N=50 (71.4%). Older women aged 35-45, 45 and above were less likely to 
screen compared to women aged 30 to 34 years of age (OR: 0.06). Having an educational 
background seemed to increase the likelihood to screen, twice if a woman had primary 
education (OR 2.0) and almost three times (OR 2.67) if a woman had a secondary or a 
higher education.  More than half of the respondents considered themselves at risk for 
cervical cancer N=42 (60.8%) and almost all showed a willingness to screen in the future 
N=64 (93%). 
Conclusion 
Most of the women in this study had never been screened for cervical cancer in their 
lifetime as reflected by n=55 (82%) while only n=14 (18%) ever screened for cervical 
cancer. The results of this study cannot be generalised to the population due to the small 
sample size.  However, there is need to facilitate comprehensive health education and the 
implementation of cervical screening programmes to target women in rural communities 
to contribute to the success of the cervical screening programme. The results of this study 
showed that 60% of respondents were informed by health care professionals on cervical 
cancer screening. Health care workers also should play a vital role in educating 
communities on cervical cancer and on the benefits for cervical cancer screening, through 
reaching all patients who utilise health care services with cervical cancer information and 
also communities through outreach programmes. 
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OPSOMMING 
Titel: Vrouens se bewustheid, houding en ervarings  van smeertoetse en servikale 
karsinoom in die landelike gebiede van KwaZulu-Natal 
Agtergrond 
Servikale kanker is geïdentifiseer as die tweede mees algemene karsinoom in vrouens en 
dra by tot die hoë sterftesyfer in vrouens.  Van al die tipes karsinoom wat by vrouens 
voorkom, is servikale karsinoom die tweede mees algemene karsinoom onder vrouens 
wêreldwyd.  Die beskikbaarheid  van dienste wat servikale smeer toetsing bied, is nog 
steeds ’n uitdaging in arm gebiede en daar word geskat dat meer as 50 % van vrouens in 
ontwikkelende lande nog nooit ’n toets vir enige servikale abnormaliteite gehad het nie.  
Doel 
Die doel van hierdie studie was om vrouens se bewustheid, houding en ervarings van 
servikale smeer toetsing en van servikale karsinoom in die plattelandse gebiede van 
KwaZulu-Natal te toets en om ’n beter begrip te kry van faktore wat ’n invloed het op 
toegang tot en gebruik van servikalesmeer toetsing by vrouens in landelike areas. 
Metode 
Die metode wat gebruik is, is ’n beskrywende studie waarin gebruik gemaak is van 
vraelyste om kwantitatiewe data te versamel.  Die monster het bestaand uit 69 vrouens, 
ouderdom 30 jaar en ouer, wat deelnemers was aan die “Microbicide Kliniese 
Navorsingsprojek” en wat opvolgbesoeke by klinieke gehad het tussen Julie en Augustus 
2008.  Die primêre bevinding, wie al ooit vir servikale karsinoom getoets is, is bereik deur 
die inligting in die laboratorium verslae van die vroue na te gaan.  Die sekondêre 
bevinding was om die deelnemers se kennis en persepsies aangaande servikale karsinoom 
te toets.  Sosio-demografiese faktore wat verband hou met of deelnemers ooit getoets is, is 
ook ondersoek. 
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Resultate 
Van die 69 vrouens, het slegs N=13 (18.8 %)  gerapporteer dat hulle ooit getoets is vir 
servikale kasinoom.  Meer as die helfte van die vrouens wat ooit getoets is vir servikale 
karsinoom het gerapporteer dat ’n gebrek aan inligting ’n weerhoudende faktor was tot die 
toetse, N=50 (71.4%).  Ouer vrouens tussen die ouderdom van  35 – 45, 45 en ouer was 
minder bereid om te toets in vergelyking met vrouens tussen die ouderdom van 30 tot 34 
(OR:  0.06).  Dit blyk asof skoolonderrig die kanse op toetsing verhoog, vrouens met 
primêre skoolopleiding se kanse dat hulle getoets is, is twee keer groter (OR 2.0) en amper 
drie keer meer (OR 2.67) as ’n vrou sekondêre onderrig of hoër onderrig  ontvang het.  
Meer as die helfte van die respondente dink hulle loop ’n risiko om servikale kanker te kry 
N=42 (60.8%) en feitlik almal was bereid om hulle te laat toets in die toekoms N=64 (93 
%). 
Bevinding 
Die meeste vroue in hierdie studie n=55 (82%) was nog nooit in hul leeftyd getoets vir 
servikale karsinoom nie terwyl slegs n=14 (18%) ooit getoets was vir servikale karsinoom. 
Die resultate van hierdie studie kan nie veralgemeen word nie, aangesien die navorsings-
populasie as gevolg van die klein steekproef te klein was. Nietemin is daar ‘n behoefte vir 
die fasilitering van omvattende gesondheidsopvoeding en die implementering van 
servikalesmeer toetsing programme. Die resultate van hierdie studie het aangedui dat 60% 
van die respondente deur professionele gesondheids werkers ingelig is met betrekking tot 
servikalesmeer toetsing. Gesondheidswerkers behoort ‘n vitale rol te speel in die 
opvoeding van gemeenskappe in verband met servikale karsinoom en die voordele van 
hiervan deur alle pasinte wat gesondheidsdienste benut in te lig omtrent servikale 
karsinoom en ook deur middel van gemeenskaps-uitreikings programme. 
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CHAPTER 1:  
ORIENTATION TO THE STUDY 
1.1 INTRODUCTION 
Cervical cancer forms in the tissues of the cervix (the organ connecting the uterus and 
vagina).  It is usually a slow-growing cancer that may not have symptoms but can be found 
with regular Pap tests (a procedure in which cells are scraped from the cervix and looked at 
under a microscope).  Cervical cancer is almost always caused by Human Papillomavirus 
(HPV) infection.  Cervical cancer is malignant neoplasm of the cervix uteri or cervical area. It 
may present with vaginal bleeding but symptoms may be absent until the cancer is in its 
advanced stages (WHO/ICO Information Centre on HPV and Cervical Cancer, 2009). 
Treatment consists of surgery (including local excision) in early stages, and chemotherapy 
and radiotherapy in advanced stages of the disease. 
Pap smear screening can identify potentially precancerous changes. Treatment of high-grade 
changes can prevent the development of cancer. In developed countries, the widespread use of 
cervical screening programs has reduced the incidence of invasive cervical cancer by 50% or 
more (American Cancer Society, 2009:10). Human Papilloma Virus (HPV) infection is a 
necessary factor in the development of nearly all cases of cervical cancer. 
Cervical cancer is a typically slow-growing cancer that may not have symptoms but can be 
early diagnosed by doing a Pap smear.  The burden of disease due to transmissible diseases 
such as HIV and Human Papilloma Virus (HPV) is increasing especially in developing 
countries.  Research has shown that HPV is the cause of about 70% of all cervical cancers 
(WHO/ICO, 2010).  Leroy, Ladner, De Clercq, Meheus, Nyiraziraje, Karita and Dabis 
(1999:104), and Tate and Anderson (2002:881) have shown a statistical significant 
relationship between HIV, HPV and cervical abnormalities.  According to the World Health 
Organization (WHO) Information Centre on HPV and Cervical Cancer, 2009 report, cervical 
cancer is currently the primary cancer in women in South Africa with an annual new case 
incidence of 6 742, in African women.  It is estimated that the annual number of new cases 
worldwide, is as high as 493 243.  Deaths due to cervical cancer amount to 273 505 women 
worldwide and 3 681 in South Africa (WHO/ICO Information Centre on HPV and Cervical 
Cancer, 2009).  
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Knowledge about the disease and risk factors are therefore important in determining 
appropriate health seeking behaviours with the aim to prevent invasive cancer and reduce 
mortality rates.  Chapter one orientates the reader to the rationale of the problem and an 
overview of the research methodology on familiarity of women regarding cervical cancer. 
This research study will provide insight into the knowledge level and experiences of rural 
women to screening and cancer, and also explore the factors influencing access to screening 
services. 
1.2 RATIONALE  
The South African policy on cervical screening recommends that all women over 30 years of 
age should have three free Pap smears at ten-year intervals.  This screening campaign is 
aimed to achieve 70% coverage by 2010 (Kawonga & Fonn, 2008:32).  It is regrettable to 
state that coverage remains sub-optimal and it is estimated that more than 50% of women in 
South Africa never had a single screening test for cervical abnormalities.   
A study conducted in rural KwaZulu-Natal to determine baseline data regarding knowledge 
about risk factors for cervical cancer showed a low uptake of the Pap smear test and a low 
level of knowledge on the prevention of cervical cancer, risk factors, and the uptake of 
cervical screening.  The study reported that only 6% had knowledge on all the risk factors 
while 65% knew only one of the risk factors of cervical cancer.  Less than half (49%) of these 
participants correctly stated that the Pap smear screening test is used for early detection of 
cervical cancer and only 18% had ever been screened for cervical cancer (Hoque, Hoque & 
Kader, 2008:112).  
A further concern is mentioned by Bärnighausen, Tanser & Newell (2009:407), where they 
state that there is no decline in the high HIV incidence in Kwa-Zulu Natal, which strongly 
relates to the higher incidence of HPV and cervical cancer in the area. 
1.3 PROBLEM STATEMENT 
The problem identified is that more than 50% of rural women in South Africa have not been 
exposed to cervical screening and there is a lack of knowledge regarding risk factors related to 
cervical cancer and the screening for and prevention of cervical cancer.  
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1.4 RESEARCH QUESTION 
The question that the researcher wishes to answer is what are the factors influencing women’s 
awareness, knowledge and experience of cervical cancer and cervical cancer smear screening 
in the rural population of KwaZulu-Natal? 
1.5 AIM OF THE STUDY 
The overall goal of the study was to explore and describe factors contributing to women’s 
awareness, knowledge and experiences regarding cervical cancer and cervical cancer smear 
screening.  
1.6 OBJECTIVES 
The specific objectives were to  
 determine the rate of screening for cervical cancer among women aged 30 years and 
above in rural KwaZulu-Natal, 
 explore and describe the knowledge and perceptions of women on cervical cancer and 
cervical cancer smear screening in this rural population. 
 identify and characterise socio-demographic factors associated with accessing cervical 
cancer screening services by women aged 30 years and above, 
1.7 RESEARCH METHODOLOGY   
The methodology used in this study was a descriptive design with a quantitative approach. 
The self-designed structured questionnaire was used to collect quantitative data on awareness, 
knowledge and experiences of rural KwaZulu-Natal women on cervical cancer and cervical 
cancer screening. The sample was a convenience sample as eligible women, aged 30 years 
and above, who were already randomized to the Microbicide clinical trial at the three 
UMkhanyakude district clinics were asked to participate as they came to the clinics.  
The research instrument was piloted on a sample of five women who were comparable to 
sample respondents in terms of socio-demographic and geographic characteristics.  This was 
conducted in July 2008 at Somkhele Clinic.  
1.8 DEFINITIONS 
For the purpose of this study the following terminology is defined and further explained. 
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Awareness 
Awareness is described as appreciation, familiarity, knowledge, observation or understanding 
(Oxford Concise English Dictionary 1995). For this study awareness meant “being familiar 
and also knowledgeable about cervical cancer and cervical cancer smear screening.” It also 
relates to the experience and perceptions influencing the uptake of cervical screening services. 
Cervix 
The cervix is the lower part or neck of the uterus forming the opening to the vagina. It is 
divided into 2 parts, namely the endo-cervix, internal part and ecto-cervix, the outer part that 
is next to the vagina (Pocket Medical Dictionary, 2003: 57). 
Cervical cancer 
Cervical cancer relates to the actual neoplasma cancerous cell changes in the cervix 
commonly referred to as carcinoma in situ (cancerous growth localised) and invasive cancer 
(cancer spreads to nearby organs).     
Cervical screening  
For the purpose of this study cervical screening relates to early detection of pre-cancer lesions 
through a Papanicolau smear (Pap).  
A Papanicolau test is a screening tool used to detect cervical abnormalities.  Mucus and cells 
are collected from the ectocervix and endocervix, by scraping and then fixed onto a glass slide 
and sent to the Cytopathology laboratory for assessment (American Cancer Society, 2009: 
10).  
1.9 SUMMARY 
Chapter one has given the introduction and orientation of the study, the research problem, 
goals, methodology and design, the ethical considerations and the further outlay of the 
research report, as well as the operational definitions.  The next chapter will discuss a 
comprehensive review of literature on the topic and related matters of the study. 
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CHAPTER 2:  
LITERATURE REVIEW 
2.1 INTRODUCTION 
Chapter one addressed the orientation to the study as well as the purpose thereof, and a 
synoptic overview of the research methodology that was implemented in this research.  A 
detailed literature search was conducted using Pub Med, and the relevant literature was 
reviewed.  The output of the review is aimed at conceptualising the history and present status 
of cervical cancer, the uptake of screening services and factors influencing access.  Where 
relevant, studies conducted in other countries were reviewed and important findings briefly 
summarised to explain the extent of the problem and related factors in other areas. This 
chapter provides a comprehensive overview of the literature on the topic: Awareness, 
Knowledge and Experiences of women regarding Cervical Cancer.  
2.2 CERVICAL CANCER 
Cancers can be caused by DNA (Deoxyribo-Nucleic Acids) mutations (gene defects) that 
activate cells promoting cell division (oncogenes).  Sometimes this could be caused by 
inactivation of tumour suppressor genes, resulting to abnormal proliferation of cervical cells.  
Cancer of the cervix occurs as a result of abnormal cell changes in the tissue layers of the 
cervix.  It may appear as a cauliflower-like growth that bleeds easily on contact (Smeltzer & 
Bare, 2004:1379). 
Hawes, Critchlow, Faye Niang, Diouf, Aissatou, Touré, Kasse, Dembele, Coll-Seck, Kuypers 
and Kiviat, (2002:555) and Khan, Castle, Lorincz, Wacholder, Sherman, Scott, Rush, Glass 
and Schiffman, (2005:1073) have shown that the most common risk factor for cervical cancer 
is the Human Papilloma Virus (HPV), which is thought to produce proteins that cause 
proliferation of cervical lining cells leading to cancer (American Cancer Society, 2009:1).   
Cervical cancer usually starts in the cells on the surface of the cervix, involving columnar or 
squamous cells.  The cells mostly affected are squamous cells. Progression of pre-cancer 
lesions (dysplasia) is usually slow and detection of early pre-cancer lesions can easily be 
achieved through Pap smear testing and is 100% treatable (Cervical Cancer Health Guide, 
2008:2).  If left undetected, pre-cancer lesions can develop into cervical cancer and eventually 
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spread to adjacent organs such as the uterus and ovaries, bladder, intestines and liver.  The 
Human Papilloma Virus (HPV) spreads through sexual intercourse and is responsible for 
almost all cervical cancers (Cervical Cancer Health Guide, 2008:2).  In countries where 
resources are allocated to prevention initiatives the prevalence and mortality of cervical 
cancer is lower, for an example in developed countries. Screening for cervical cancer is 
important so as to ensure early detection of pre-cancer lesions to reduce the incidence of 
mortality due to cervical cancer in the population (Adanu, 2002: 286). Knowledge and the 
attitude of the women to smear testing are important in improving the understanding of 
factors influencing the uptake of diagnostic services available.  
2.2.1 Cervical cancer risk factors 
Different cancers have various risk factors. It is important to note that although the presence 
of cervical cancer risk factors increase the odds of a woman getting cervical cancer in her 
lifetime, not all women exposed to risk factors develop cancer. Several risk or predisposing 
factors were identified and discussed.  
2.2.1.1 Human Papilloma Virus (HPV) 
The most important risk factor for cervical cancer is the sexually transmitted HPV.  HPV 
infection is mostly prevalent in young women under 30 and less in older women over 30 
years.  There is currently no cure for HPV infection apart from management of lesions or 
growths caused by HPV infection (American Cancer Society, 2009:1).  HPV type 16 and type 
18 cause approximately 70% of incidences of cervical cancer worldwide, although there are 
variations across countries.  Early studies have shown a relationship between HPV and 
cervical neoplasma.  In a study conducted in Denmark 1998, women with high risk of HPV 
infection had a 33-fold increased risk of cervical neoplasma compared to HPV-negative 
women.  In the same study it was found that HPV test has a higher sensitivity than a Pap 
smear test (Kjaer, 1998:2). Women who were HPV positive for type 16 and 18 were found to 
be at a higher risk of developing cervical cancer lesions when followed over a 10-year period 
(Khan, Castle, Lorincz, Wacholder, Sherman, Scott, Rush, Glass and Schiffman, 2005:1073).  
This further suggests evidence of HPV as a significant risk factor for cervical cancer. 
2.2.1.2 Weakened Immune System 
Chirenje, Loeb, Mwale, Nyamapfeni, Kamba and Padian (2002:766); Hawes, Critchlow, Faye 
Niang, Diouf, Aissatou, Touré, Kasse, Dembele, Sow, Coll-Seck and Kiviat (2003:566); and 
Leroy, Ladner, De Clercq, Meheus, Nyiraziraje, Karita and Dabis (1999:104), concur  that the 
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highest burden of pre-cancer lesions is among HIV infected women and in some cases co-
existence of HPV infection also increases this risk.  In addition to HIV seropositivity as a risk 
factor, Ruche, Ramon, Mensah-Ado, Bergeron, Diamondé, Sylla-Koko, Ehouman, Touré-
Coulibaly, Welffens-Ekra and Dabis (1998:2403), argue that other factors significantly 
associated with cervical lesions should also be considered, such as smoking, parity (given 
birth) three times or more three, low educational level and non-usage of oral contraceptives.  
Conversely, early sexual debut and multiple sexual partners, which are known to be risk 
factors for cervical cancer, were not associated with increasing risk in this study (Ruche et al., 
1998:2403).  Some studies have shown a significant association between recurrences of 
cervical dysplasia after therapy or a hysterectomy in women who are HIV infected (Tate & 
Anderson, 2002:881).  Therefore, there is an increasing concern for cervical cancer screening 
for women living with HIV, though this remains a challenge for low-resource settings.  The 
National Health Departments should encourage Pap smear testing for all patients who are HIV 
infected to facilitate early diagnosis and prompt management. 
2.2.1.3 Smoking 
The risk of developing cervical cancer is doubled in smoking women compared to non-
smokers due to exposure to high levels of carcinogens in smoke.  Carcinogens are thought to 
damage the DNA of cervical cells, leading to cervical cancer (American Cancer Society, 
2009:2).  It is of interest to learn how women smokers and non-smokers perceive their risk.  
In a study conducted among 722 women ranging between 20 and 64 years, smokers did not 
perceive themselves to be at high risk.  The intention to attend a cervical screening was 
similar among both groups of smokers and non-smokers (Marteau, Hankins and Collins, 
2002:20); although smoking among African women is not highly prevalent, there is a need to 
raise awareness in all communities in this regard.  In South Africa smoking among women 
contributes 7.70% of cervical cancer (WHO/ICO Information Centre on HPV and Cervical 
Cancer, 2007:1).  
2.2.1.4 Other risk factors 
The other risk factors include: a family history of cervical cancer, early sexual debut, age, a 
lack of regular Pap smear testing, as well as the number of pregnancies (American Cancer 
Society, 2009:4; Ruche, Ramon, Mensah-Ado, Bergeron, Diamondé, Sylla-Koko, Ehouman, 
Touré-Coulibaly, Welffens and Dabis, 1998:2401).  In a study conducted in Mali among 
women with invasive cancer, an increase in the number of pregnancies increased the risk of 
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cervical cancer, this relationship was statistically significant.  In addition early sexual debut 
increased odds of invasive cancer (Bayo, Bosch, de Sanjose, Munoz, Combita, Coursaget, 
Diaz, Dolo, van den Brule and Meijer, 2002:206). 
2.2.1.5 The link between cervical cancer and HIV and AIDS 
The HIV incidence remains high in this rural KwaZulu-Natal population and has remained 
high over a 5 year period, from 2003-2007.  The results from a large population-based 
longitudinal surveillance in this rural population showed the overall incidence of 3.4 per 100 
person-years (Confidence interval 3.1-3.7).  These results were similar to those reported in a 
longitudinal population-based study in another rural population, 4.9 and 2.2 per 100 person-
years in women and men respectively (Bärnighausen, Tanser & Newell 2009:407).  Both HIV 
and cervical cancer are regarded as sexually transmitted infections which initially do not show 
symptoms until the progression of the disease. Research studies suggest that the lifespan of 
women living with HIV is elongated through the use of HAART (highly active antiretroviral 
therapy), which results in an increased risk of contracting cervical cancer (Health Systems 
Trust, 2009:1).   
The relationship between HIV and cervical cancer has been established through several 
studies conducted in Africa on HIV negative/ HIV positive women.  HIV positive women 
with cervical pathologies quickly progress to invasive cancer compared to HIV negative 
women (Health Systems Trust, 2009:1, Chirenje et al., 2002:766, Ruche et al., 1998:2401, 
Franceschi & Jaffe, 2007:510).  Franceschi and Jaffe (2007) further emphasize the need for 
offering cervical screening to all women who are HIV positive so as not to miss the 
opportunity of preventing invasive cancer. HPV has been identified as an important risk factor 
for cervical cancer.  Alternative methods to reduce the incidence of invasive cervical cancer 
resulting from HPV infection have been researched and explored.  As a result two vaccines 
have been developed to curb the risk of cervical cancer caused by HPV.  The challenge would 
be dissemination of information to the communities about the vaccine coupled with 
availability issues in resource-poor settings (Moodley, 2009:12).  
2.3 CERVICAL CANCER PREVALENCE AND BURDEN 
The information below provides a comprehensive overview of the global cervical cancer 
prevalence and burden. 
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The global prevalence of cervical cancer is estimated to be 2.3 million and the incidence to be 
500000.  Cervical cancer is the second leading cause of cancer in females in developing 
countries and first in developed countries.  The Human Papilloma Virus (HPV) contributes to 
over 70% of all cervical cancer cases, of which 41-67% is high-grade lesions and 16-32% are 
low-grade cervical lesions.  Cervical cancer screening is important to diagnose pre-cancer 
lesions early.  The crude incidence rate and standardized incidence ratio is estimated to be 16 
and 100 per 100000 women respectively.  The mortality rate of cervical cancer is estimated to 
be 8.9 per 100000 females globally and the cumulative risk to be 0.7%.  The risk of cervical 
cancer tends to increase with age, reaching the peak point in 35 per 100000 women from 55-
64 years age groups.  This rate is doubled in South Africa (WHO/ICO Information Centre on 
HPV and Cervical Cancer, 2007:5-14).   
2.3.1 The prevalence and burden of disease in South Africa 
In South Africa cervical cancer incidence has doubled compared to the global estimates and 
has the highest rate compared to other cancers at 30.2 per 100000 females followed by breast 
cancer at 27.0 per 100000 females.  The number of new cases is higher in women aged 15-44 
and gradually decreases with age, conversely the death rate increases with age, since pre-
cancer lesions may take years to develop to invasive cancer.  More than 80% of cases 
diagnosed with HPV are found to have higher-grade lesions or cervical cancer; 88.4 and 
93.8% respectively (WHO/ICO Information Centre on HPV and Cervical Cancer, 2007: 8-
15).  
2.3.2 The Burden of disease in KwaZulu-Natal 
In KwaZulu-Natal between 1997 and 2001 about 48% of the total deaths reported were due to 
degenerative diseases, including the central venous system (CVS) and neoplasma.  In females 
neoplasma was ranked the second cause of mortality contributing to about 14% of deaths.  
Among those females dying from cancer the most common cancer is that of the reproductive 
system, cancer of the cervix (KwaZulu-Natal Epidemiology Bulletin, Department of Health, 
2003:4).  
2.4 CERVICAL SCREENING IN SOUTH AFRICA 
When the Papanicolau smear (Pap) test was introduced as one of the cervical cancer screening 
methods, the health authorities in most countries adopted this screening method in their 
annual screening policies.  In developed countries this was mainly the responsibility  of the 
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health care workers to keep a national register and mail invitation letters to women as 
reminders for annual smear tests when due.  Historically, in developing countries, however, 
funds were mostly channelled to the management of the late stage cancer as opposed to early 
detection measures.  Women were thus left at risk due to inadequate preventive care 
(Lovejoy, 1996: 128). 
The World Health Organization has stipulated the target of women for cervical screening to 
be those aged 30 and above and also recommended reducing the number of cervical cancer 
smears to one per woman per lifetime.  The South African National Department of Health 
proposed a total of 3 cervical cancer smears per lifetime beginning at age 30 and above and 
also that these are  spaced at  10 year intervals.  The premise behind this policy is that cervical 
cancer develops over time; it may take 10-20 years for a pre-cancer lesion to progress to 
cervical cancer.  Younger women under 30 years usually present with low grade lesions that 
regress to normal over time.  The mean age of patients with high-grade lesions is 30 years and 
the time estimated for progression to invasive cancer is 10 years.  If a cervical cancer smear is 
sensitive enough it should be able to diagnose cervical abnormality early enough so as to 
facilitate preventive measures.  Women with abnormal cervical smear results require referral 
for colposcopy and for further management (Department of Health: National Guidelines on 
cervical cancer, 2000:3).  
The South African National Cancer Control Programme was adopted as the official 
government policy in 1997 and its implementation is decentralized to provincial and local 
structures.  The challenge of inadequate resources e.g. poor transport systems, lack of 
accessible laboratories and also low uptake of this service is still evident in some provinces.  
The Department of Health has estimated that in order to achieve 70% coverage of the 
population, over five million women would need to be screened over the next 10 years.  Some 
of the cervical screening challenges are that most women in developing countries only seek 
health care when they are in the advanced cervical cancer symptomatic stages (Moodley, 
2009:11-12).  
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2.5 LITERATURE TO EVALUATE WOMEN’S KNOWLEDGE, AWARENESS AND 
EXPERIENCES REGARDING CERVICAL CANCER AND CERVICAL 
CANCER SCREENING. 
Various studies have been conducted globally to evaluate women’s awareness of cervical 
cancer and screening practises.  In a qualitative study conducted in West Virginia to evaluate 
awareness and knowledge of cervical and breast cancer among women, it was found that 
women were more knowledgeable about breast cancer than cervical cancer.  Some of the 
common misconceptions were on the frequent use of tampons during menstruation as the 
cause of cancer. Some also believed that women who had a hysterectomy performed, 
regardless of the indication, do not require cervical screening in the future (Lyttle & 
Stadelman, 2006:4).  These misconceptions could negatively impact on the future uptake of 
cervical screening services.  Barriers to screening were mostly cost-related as women in 
developed countries are expected to pay in order to access such services. The other barriers 
were fear of the unknown, embarrassment, denial, lack of time and lack of transportation. 
Lack of motivational factors were cited and therefore there is a need for further interventions 
such as increased educational campaigns by health care professionals, the buddy system 
where the relative or friend could accompany each other to the health care service and 
motivation by health care providers to encourage women to go for testing.  Women also 
advised that educational campaigns should be varied e.g. that television programs, the radio, 
mail and contact sessions be utilised and they also emphasized the importance of varying 
educational techniques by various educators to cater for different age groups (Lyttle & 
Stadelman, 2006:4-5).   
In a quantitative study conducted to assess knowledge, perceptions and attitudes of health care 
professionals in the U.S.A, findings were that most professionals are knowledgeable about 
risk factors of cervical cancer.  However, they cited the lack of time and resources in offering 
educational information on cancer to patients.  Preventive counselling to reduce the risk of 
cervical cancer was viewed as of less importance to the professionals (Tessarro, Herman, 
Shaw and Giese, 1996:272).   This implies that no matter how knowledgeable health care 
professionals are, sharing information with patients and communities is of greater benefit to 
reduce the risk of cervical cancer.   
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Most studies conducted globally have indicated lack of knowledge and awareness in women 
regarding cervical smear testing and cervical cancer.  This has resulted in a low uptake of 
screening services.  In a qualitative study conducted among women aged between 21 and 56, 
most women had a poor knowledge of cervical cancer (Wong, Wong, Low, Khoo and Shuib, 
2009: 51).  Most of them had heard of cervical cancer previously but were not aware that it 
could be prevented.  Only a few older, married women were aware that if cervical cancer is 
detected early it could be managed.  The role of the Pap smear in early detection was also 
poorly understood.  Only less than half of women recognized the risk factors.  Most 
surprisingly, most of these women thought the Pap smear is performed to diagnose sexually 
transmitted infections, and the procedure itself was not well understood (Wong et al., 2009: 
51). These findings indicate that a lot needs to be done to increase public awareness, 
knowledge and insight of women regarding the importance of early screening for cervical 
cancer.  Educational messages should reach all women regardless of educational level, race or 
socio-economic status.  Most of the women who participated in the above study had a 
secondary education.  This shows that the educational level would not contribute much to the 
assimilation of health education messages.  
In a study conducted in Nigeria amongst professionals, other public servants and students, the 
level of awareness of cervical screening was average (52.8%), however only 7.1% had ever 
done a Pap smear test.  The most common reasons given for not doing a Pap smear test 
included the  lack of awareness (46%), fear of a bad result and some felt there was no need for 
it (Ezem, 2007:94-96).  One would expect the level of awareness to be higher in this sample.  
However, this result attests to findings from other countries.  Women do not access screening 
services despite awareness about such services.  In most cases the proportion of women who 
had ever had a Pap smear is far less than half of the women who reported an awareness of the 
Pap smear.  Almost half of the women in a study conducted in Ghana reported doing a Pap 
smear, because the doctor asked for it as part of patient management.  Results also showed 
that although 93% of women have heard of cervical cancer, only 37% of those had adequate 
knowledge about this disease.  Of those with adequate knowledge, only 8.5% have ever had a 
Papanicolau (Pap) smear done (Adanu, 2002: 487).   In a study to evaluate availability of 
screening services in African countries it was found that 95% of health institutions at all 
health care levels had basic infrastructures to perform cervical cancer screening (Chirenje, 
Rusakaniso, Nyamapfeni, Kamba and Padian, 2001:127-128).  
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Earlier studies conducted in South Africa (Cape Town) also revealed a lack of knowledge on 
cervical cancer and Pap smears.  None of the women interviewed knew what a cervix was; 
however, they could easily recognize the word Pap smear and link it to cancer of the uterus.  
Most women thought the Pap smear was done to diagnose infections, infertility and also to 
clean the uterus following severe vaginal bleeding or miscarriage.  Only a few participants 
linked Pap smears to cervical cancer diagnosis.  The reasons for doing a Pap smear are mostly 
linked to ill health and also as per nurse instructions.  This indicates that the use of the Pap 
smear as a screening test for early pre-cancerous lesions is poorly understood.  Some of the 
obstacles to Pap smear verbalized by women are: fear, embarrassment, lack of time and 
stigma (Abrahams, Wood and Jewkes, 1996:14-21).  The study conducted in the rural 
KwaZulu-Natal population showed similar results (Hoque, Hoque and Kader, 2008:113-115). 
The uptake of cervical screening is still very low despite these services being cost-free in most 
regions.  Research evidence suggests that factors such as knowledge, attitude and awareness 
play a vital role in the utilizing of this service. There is also no significant difference between 
women who attend and non-attenders in respect of knowledge (Twinn, Shiu and Holroyd, 
2002:379).  This indicates that lack of education and knowledge does not exist as a main 
barrier to women attending clinics for cervical cancer screening.  In a survey conducted to 
assess barriers and women experiences to pap smear testing in the same geographic area in 
KwaZulu-Natal, women displayed that they had information about the need for cervical 
screening.  In almost all women interviewed, the motivator for cervical screening was the 
invitation they got from the professionals and also the pelvic symptoms they experienced 
(Wood & Jewkes, 1996:9).  The same study found an association between promiscuity and 
cervical cancer, which may result, in low utilization of the screening service (Wood & 
Jewkes, 1996:10).  A recent study (2008) conducted in one of the tertiary institutions in 
KwaZulu-Natal reported a lack of knowledge regarding cervical cancer and cervical 
screening.  Less than half of the students had heard of cervical cancer and the risk factors 
were poorly understood.  Half of the students mentioned HPV as the main cause of cervical 
cancer.  The main reasons for not doing a cervical screening test were fear and being healthy 
(Hoque & Hoque, 2009: 21-24).  The above implies that there is a need for health education 
and making the communities aware of the importance of cervical cancer screening so as to 
increase the utilization of cervical screening services.  Unlike the other countries, the issue of 
cost as a barrier to screening was perceived differently in KwaZulu-Natal; professionals who 
interviewed patients did not identify the cost for the smear as a problem.  They explained that 
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women often interpret “no charge” with poor quality service.  This is unfortunate as most 
women benefit from free primary health services and the bulk of the women in this area are 
unemployed. Barriers that surfaced were mostly the lack of trained staff to provide service 
and education, as well as women’s reluctance and fear caused by misunderstanding and lack 
of motivation and anxiety.  The other important barrier was the lack of adequate 
communication with clinicians, especially of the referring hospital.  This then had a negative 
impact on an appropriate follow-up care of patients.  In addition, when referred, women often 
resisted attending further investigations following abnormal smears (Wood & Jewkes, 1996: 
14-15). 
2.6 ACCESS AND UTILISATION OF CERVICAL SCREENING SERVICES 
The prevalence of cervical cancer has been greatly reduced through successful cervical 
screening programmes especially in developed countries.  Most developing countries are still 
faced with challenges of implementing such services.  Success depends on a number of 
factors, such as coverage of the right target women, excellent follow-up service, early 
management of pre-cancer lesions and resource availability (Pollack, Balkin, Edouard, Cutts 
and Broutet, 2007:57).  Research conducted in other countries among women who had 
cervical cancer has shown a significant relationship between age and failure to screen, older 
women are more likely not to screen compared to younger women.  The other important 
factors to be considered to ensure that cervical screening contributes to prevention of invasive 
cancer are: diagnostic failure whereby the screening test is unable to detect precancerous 
lesions due to poor techniques. The aim also is reaching a greater percentage of women who 
have not had a recent Pap smear. This is to diagnose undetected precancerous lesions early 
before the condition develops into cervical cancer (Leyden, Manos, Geiger, Weinmann, 
Mouchawar, Bischoff, Yood, Gilbert and Taplin, 2005:677).  There is a need to periodically 
review health services to ensure that all factors influencing access to these services are 
addressed.   
Studies conducted in Africa show that above 95% of health care institutions have basic 
infrastructures to conduct cervical screening.  Most screening was provided on demand 
through family planning services.  The most common barriers to providing cervical screening 
tests were a lack of a clear policy and procedures, and also staff competencies.  Most smears 
were evaluated in tertiary hospitals and this caused delays in turnaround times of results.  
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Most women commonly screened were below 25 years and also women with invasive cervical 
cancer (Chirenje et al., 2001:128-129).  
Data from the Western Cape, South Africa, indicates that in the year 2005, 45 997 (74%) of 
the total women screened were over the age of 30 years.  Abnormalities were detected in 
7.3% of the Pap smears taken.  This is encouraging although much needs to be done to reach 
100% of eligible women.  In KwaZulu-Natal 28 760 Pap smears were performed in 2005, 
accounting for 26% of the target.  This indicates that a large pool of women remains 
unscreened.  Reaching the 70% National target coverage remains a challenge.  The other 
factor is that a low percentage of women who have ever done a smear test are not informed of 
the purpose of the test (Moodley, 2009:12).   
2.7 SUMMARY  
From this comprehensive review of literature it is apparent that cervical cancer screening 
knowledge is essential as a health promotion strategy.  The burden of disease due to cervical 
cancer is high and also poses a challenge to the overburdened health care systems in 
developing countries.  This review formed the basis for the questionnaire and the research 
design that was utilized in this study.  Few studies have been conducted in this province to 
assess the level of knowledge, awareness and attitudes of women to Pap smear testing and 
cervical cancer.  This study will add to the body of knowledge, which would help in re-
enforcing prevention messages and cervical cancer information.  It would also provide a basis 
for exploration of key issues through a qualitative approach in the future. In the next chapter 
the methodology implemented for this research study which explored women’s awareness, 
knowledge and experiences regarding cervical cancer in rural KwaZulu-Natal, South Africa 
were discussed.  
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CHAPTER 3:  
METHODOLOGY 
3.1 INTRODUCTION 
Chapter two provided a comprehensive overview of the literature on the topic: women’s 
awareness, knowledge and experiences regarding cervical cancer and screening and related 
matters.  This chapter describes the methodology that was used in this study.  According to 
Burns and Grove (2001:26) research methodology is “the application of all steps, strategies 
and procedures for gathering and analysing data in a research investigation in a logical and 
systematic way”. This can be defined as the research plan that guides the research.  It 
involves a research design, sampling methods, data collection methods and analysis, and 
ethical considerations.   
3.2 THE PURPOSE OF THE STUDY 
The aim of this study was to assess women’s awareness, attitudes and experiences regarding 
cervical cancer smear screening and cervical cancer in rural KwaZulu-Natal, and to better 
understand the factors that influence access to and utilization of cervical screening services by 
rural women.  In resource-poor settings, access to services offering cervical screening is still a 
challenge and according to Adanu (2002:486), it is estimated that more than 50% of women 
in developing countries have never had a single screening test for cervical abnormalities. 
3.3 THE RESEARCH OBJECTIVES 
This study was guided by the following objectives to: 
1. determine the rate of screening for cervical cancer among women aged 30 years and 
above in rural KwaZulu-Natal; 
2. explore and describe the knowledge and perceptions of women on cervical cancer 
and cervical cancer screening in this rural population. 
3. identify and characterize socio-demographic factors associated with accessing 
screening services in women aged 30 years and above and 
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3.4 THE RESEARCH DESIGN 
A research design “guides the researcher in planning and implementing the study in a way 
that is most likely to achieve the intended goal” (Burns & Grove 2001:223).  This was a 
descriptive study, using a questionnaire to generate quantitative data to gain insight into 
participants’ awareness, knowledge and experience relating to cervical cancer and cervical 
cancer screening. 
A descriptive study aims to quantify the problem, giving detailed information and also taps 
into perceptions of communities and groups.  Some literature describes descriptive studies as 
hypothesis-generating studies since they bring out questions for further research about 
situations.  The benefit of conducting such studies is that information obtained assists direct 
planners and service providers in service planning and resource allocation (Katzenellenbogen, 
Joubert & Abdool-Karim, 1999:89). 
This was a descriptive study using a structured questionnaire (Appendix A) to collect data and 
some open-ended questions which were added to the questionnaire to further explore opinions 
and perceptions. Experienced and knowledgeable registered nurses in the Microbicide clinical 
trial clinics who were utilized for research and the researcher administered the survey 
questionnaires.  These nurses were already trained in cervical cancer screening since it was 
offered as a standard of care to all Microbicide clinical trial participants.  In addition the 
researcher conducted extra two days training on the cervical cancer protocol including the 
questionnaire and the informed consent process.  Training sessions were evaluated through 
mock interviews, where data collectors were asked to conduct interviews on each other using 
the study questionnaire. This helped the researcher to identify any training gaps that had to be 
addressed before actual data collection, e.g. correct adherence to interviewer instructions, skip 
questions, correct phrasing of questions and recording. 
3.5 STUDY POPULATION AND SAMPLING 
The Africa Centre for Health and Population studies is one of the 6 sites involved in a 
multicentre trial-Double-blind, placebo-controlled Microbicide clinical trial, testing 
Microbicide gel –PRO-2000/5 for safety and efficacy in preventing vaginally acquired HIV. 
This site is situated in UMkhanyakude District, Mtubatuba, in rural KwaZulu-Natal. The 
Microbicide trial commenced in March 2006 with a target to enrol 1200 women and ended 
follow-up in August 2009. Women were recruited from district family planning and 
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immunisation clinics. Those who met the inclusion criteria were randomised into three study 
arms, namely PRO 2000 0.5%, PRO 2000, 2% and Placebo gel. Women enrolled in this trial 
were followed up over a period of a year, returning to clinic every month for follow-up care. 
They completed follow-up at different time points.  The last group of women completed 
follow-up on 28 August 2009. All the women who participated in the Microbicide clinical 
trial were offered cervical cancer screening through a Pap smear at enrolment as a standard of 
care procedure in this trial.  The researcher then identified this group of women as a sample 
for the cervical cancer study, to further explore the role of prior screening and knowledge on 
this subject. 
The initial target for the cervical cancer study was 120 participants, 10% of the Microbicide 
trial participants. However there were delays in Ethical committee approval, the cervical 
cancer protocol was initially submitted in June 2008 and only granted Ethics approval in June 
2009. Data collection commenced on 06 July 2009. Only six hundred women were still on 
clinical follow-up during that period, a convenience sample of 69 women who agreed to be 
part of the cervical cancer study was obtained.  Women were recruited from the three clinics 
at the UMkhanyakude district in rural KwaZulu-Natal, Madwaleni, Mtuba and KwaMsane 
clinics. This was a convenience sample as eligible women who were already randomized to 
the Microbicide clinical trial were asked to participate as they came to the clinics.  
3.5.1 Inclusion Criteria  
The following inclusion criterion was used to enrol women to this study: 
 Women enrolled in the Microbicide clinical trial attending clinic for Microbicide trial 
follow-up care between 06 July and 07 August 2009. 
 Participants attending MDP trial clinics aged 30 years and above. 
 The three clinics selected for sampling were all in the UMkhanyakude district in rural 
Kwazulu-Natal province.  
3.6 RELIABILITY AND VALIDITY 
Assessment of reliability is done to ensure that the research instruments measure consistently 
and accurately with repeated measures (Gerries & Lacey, 2006:376). Katzenellenbogen, 
Joubert & Abdool-Karim, 1999, defines reliability as “the degree of similarity of the 
information obtained when a measure is repeated”. The researcher tested the questionnaire by 
giving it to colleagues who are working in the same clinics (these colleagues were not part of 
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the study) to determine if all interpreted the questions similarly.  According to 
Katzenellenbogen, Joubert and Abdool-Karim 1999:124), validity is defined as the ability of 
an instrument to measure the variables that it is intended to measure.  The questionnaire was 
piloted on a sample of 5 women, aged 30 years and above, attending the family planning 
(reproductive health clinic) at Somkhele clinic. Assessment of reliability is done to ensure that 
the research instruments measure consistently and accurately with repeated measures (Gerries 
& Lacey 2006:376).  Katzenellenbogen, Joubert and Abdool-Karim (1999:124), define 
validity as the extent to which a measure actually measures what it is meant to measure.  
Attempts were made to improve and evaluate validity and reliability in this study.  This was 
ensured through standardization of the method of data collection, training of research nurses 
who were collecting data, supervision and control.   
Nurses who were assisting with data collection were trained on the cervical cancer protocol to 
ensure the high quality of data and also standardization of data collection.  Quality control of 
completed questionnaires was done by the researcher. The researcher checked questionnaires 
for completeness, consistency and legibility and where necessary meetings were held with the 
interviewers to clarify inconsistencies. Inconsistencies identified and clarified at the beginning 
of the study were partial adherence to interviewer instructions, e.g. incorrectly asking skip 
questions.  
3.7 THE RESEARCH INSTRUMENT AND DATA COLLECTION 
Data collection was through a self-designed structured questionnaire.  The questionnaires 
were formulated in English and translated into the language that is spoken by the target 
sample i.e. isiZulu by the research nurses who are trained registered nurses and the researcher 
during an interview (Cervical Cancer Questionnaire: Appendix B). The instrument was a self-
designed structured questionnaire with mainly closed-ended questions and a few open-ended 
questions. The questionnaire was typed legibly and was divided into 3 sections, namely 
section 1: Socio-demographics, section 2: knowledge/awareness, section 3: perceptions and 
experiences. Socio-demographic characteristics considered were age, marital status, 
educational status- highest level attained, employment status, earnings, and 
sexual/reproductive history. Knowledge and awareness was obtained from general knowledge 
questions on cervical cancer description, whether it is preventable and how, the cervical 
screening test type and frequency of cervical cancer screening tests. Perceptions and 
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experiences were elicited from the history of previous cervical screening, experiences and 
willingness to screen for cervical cancer in the future.   
Research nurses who assisted in data collection are registered nurses who received two days 
additional training on cervical cancer protocol, the informed consent process and 
questionnaire administration.  The extra training was conducted to ensure good data quality 
and standardization of the data collection process.  Staff training was evaluated through 
simulated interviews.  Literate participants were allowed to complete a questionnaire on their 
own with the assistance from the interviewer. The interviewer and the literate woman who 
chose to record her own responses both had copies of the questionnaire.   The interviewer then 
read out questions systematically to ensure the woman answered all questions as required. 
Women were asked (open and closed questions) about their knowledge, perceptions of 
cervical cancer and cervical screening.  The history and experiences of previous cervical 
screening were sought as well as barriers to cervical screening were identified. 
3.8 THE PILOT STUDY 
A pilot study is defined by Van Ort (1981), quoted by Burns and Grove (2009:44), as a 
“smaller version of a proposed study that is conducted to refine the methodology”.  It could be 
performed in various stages of a research process. In this study this only involved piloting the 
questionnaire during the early stages of the questionnaire formulation. 
The research instrument was piloted on a sample of five women who were comparable to 
sample respondents in terms of socio-demographic and geographic characteristics.  This was 
conducted in July 2008 at Somkhele Clinic and resulted in the following benefits: the time 
taken to complete the questionnaire was established; statements and questions that were 
misinterpreted by the respondents were re-worded and corrected. 
3.9 THE ROLE OF THE RESEARCHER 
The researcher was involved in protocol development, questionnaire design, the training of 
three registered nurses from each clinic on the cervical cancer protocol, a standardized 
method of data collection including administering the consent, data collection. The researcher 
also did quality control of data collection, analysis of data and report writing.  All completed 
questionnaires were sent to the researcher at the end of each day to be quality controlled for 
completeness, accuracy and consistency.  Data was then captured on an excel spread sheet by 
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the researcher in preparation for data analysis.  Data analysis was performed once data 
capturing of all questionnaires were complete.  
3.10 ETHICAL CONSIDERATIONS 
Research involving human subjects should always be guided by good clinical practice and 
human right principles to ensure protection of participants.  Some of the ethical 
responsibilities of researchers are to maintain privacy, informed consent-ensuring that there is 
voluntary participation, protection of participants, informing participants what the study is for, 
how information will be used and whether there is any potential risk expected 
(Katzenellenbogen et al., 1999:89). 
This study which explores women’s awareness, knowledge and experiences with regards to 
cervical cancer in rural KwaZulu-Natal was approved by the Stellenbosch University, Faculty 
of Health Sciences, Human Research Ethical Committee (HREC) on 9 March 2009 and 2 
April 2010 respectively (Appendices C01 and C02) and the study site project leader.  The 
respondents were asked to be part of the study after detailed information pertaining to the 
study was explained to them.  They were asked to sign an informed consent form as proof of 
their voluntary participation. 
3.10.1 Confidentiality and Anonymity 
The researcher used screening and trial numbers already allocated to these participants as 
identity numbers, since no names were used on any of the questionnaires except informed 
consent documents.  Full participant names were used on the informed consent forms, and 
these were kept locked separately from the questionnaires.  The participants were assured of 
confidentiality of their information during an informed consent process and privacy was 
maintained throughout. Completed questionnaires were transported from the clinics by the 
Africa Centre driver to the office in a well secured box to avoid unnecessary loss.  Data 
capturing was done by the researcher and the electronic spread sheet was saved in a password 
controlled excel folder.  
3.10.2 The consent 
The study information sheet was translated into the language spoken by participants, namely, 
isiZulu, and was made available to all participants (IsiZulu participant information sheet and 
consent: Appendix C03. Illiterate participants were assisted by interviewers to read the 
information sheet to them.  Participants were encouraged to ask questions to ensure clarity of 
22 
 
the study information.  At the end of the information session volunteers were asked to sign the 
consent document as proof of voluntary participation and also to acknowledge their 
understanding of the study information.  Illiterate participants were asked to put a thumb print 
as a signature.  The information sheets and a copy of the signed informed consent form were 
provided to participants to take with them. 
3.11 DISSEMINATION OF RESULTS 
The researcher has an ethical obligation to make research results available to all stakeholders; 
this includes participants, district clinic staff, the district hospital and the local community.  
The researcher will use feed-back systems in place at the Africa centre for this purpose such 
as community meetings, formal meetings with the hospital board and clinic staff, road shows 
and the Umbiko community magazine.  A copy of the final report will be made available to 
the Hlabisa district hospital. 
3.12 SUMMARIZING THE SAMPLE DATA 
The primary outcome measure for this analysis was whether these women had ever been 
screened for cervical cancer (Q13, section 3-have you ever screened for cervical cancer (prior 
to joining the trial?)  The primary outcome measure was assessed from the history of previous 
cervical screening obtained, which was either “yes” or “no”.  The secondary outcome measure 
employed in the analyses reflected knowledge and perceptions of women with regards to 
cervical cancer and cervical screening. Knowledge was determined through the general 
knowledge about cervical cancer, cervical cancer risks and cervical screening, Q7-12: Section 
2: Q7. What do you understand by cervical cancer? This was an open-ended question where 
respondents were expected to state in their own words what cervical cancer is., Q8 what basic 
test is conducted to screen for cervical cancer? Respondents were expected to choose from 3 
responses given. Q9 Do you have information about cervical cancer screening, if so where did 
you get this information? Q10 Mention at least 3 risk factors for cervical cancer, Q11 Can 
cervical cancer be prevented? “Yes” “no” or don’t know. Q11a if yes to q11, how? 
Respondents who knew cervical cancer could be prevented were expected to state how in 
Q11a. Q12-How often do you think women should screen for cervical cancer- four responses 
were given to choose from.  If a woman had reported previous screening her experiences and 
also intention to screen in the future were explored, also if no prior cervical screening was 
reported reasons were explored (Q13-15b). Q13a if answer to Q13 (ever screened for cervical 
cancer) was “no” women were expected to give reasons-choose from responses given. Q13b 
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if answer to Q13 was “yes” the woman was expected to share her experiences, through 
choosing from responses given or specify. Q14 cervical cancer risk established-“Do you think 
you are at risk of cervical cancer? Q15-15b were on establishing future intentions to screen- 
Q15 Would you screen for cervical cancer in the future?, and also where the woman intended 
to go for screening Q15a, if not reasons were established, Q15b.  Socio-demographic factors 
associated with previous screening for cervical cancer were explored to establish associations.  
Demographic and socio-economic characteristics included age, highest educational level 
achieved employment status, monthly earnings and marital status.  Age was assessed as 
categorical variable (30-34, 35-44, 45+, year age groups) throughout the analysis.  Highest 
educational level achieved was also assessed as categorical variable (no education, primary 
education, secondary education, matriculation or above).  In addition, education was 
evaluated as a categorical variable (no education, primary, secondary or higher throughout).  
Employment status was categorized as a binary variable namely being unemployed versus 
being in either part-time or full-time employment.  Earnings (women who were employed) 
were classified as categorical variable (R500 or less, R501-R1000, R1001-R2000, R3000+).  
Marital status was treated as a binary variable of being married or unmarried.   
Other variables included age of sexual debut, parity and contraception.  The age of sexual 
debut was represented by categorical variable with sexual initiation below 15, between 16 to 
19, or 20 + years of age.  Parity was reported as ordinal categorical variable (0, 1-3, 4-5, 5+).  
Contraception usage was reported as binary variable of using or not using any method of 
contraception.  Contraceptive type was also reported as (pills, injectable, sterilization, condom 
or other).  
All questionnaires were inspected for completeness and consistency of responses e.g. whether 
all questions were answered, skip questions followed accurately, legibility of handwriting.  
Questionnaires were transported by the Africa Centre driver from the clinics to the Africa 
Centre (where the researcher works) each day and captured into the Microsoft Office Excel 
2007 spread sheet by the researcher.   
3.13 DATA ANALYSIS 
Data was extracted from Microsoft Excel 2007 and analysed in STATA 10 (Stata 
Corporation, College Station, Texas, USA) and the SAS statistical programme for Fishers 
Exact test. The above test is used to classify objects in two different ways (categorical data) to 
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examine the significance of the contingency between the two kinds of classification (Fisher, 
1922:87-94).  Descriptive statistics (mean, standard deviation, percentages and frequency 
distribution) was used to analyse quantitative data to determine central tendency and variation 
in the data. The overall proportion of women screened for cervical cancer through a Pap 
smear was established.  In addition this proportion was broken down per socio-economic, 
demographic and sexual behaviour variables.  
The relationship of periodic screening for cervical cancer with demographic, socio-economic 
characteristics was evaluated in bivariate analysis using the Pearson-Chi Square test.  
Statistical significance between the group who had been screened and those who have never 
been screened for cervical cancer was analysed using Fisher’s Exact test and expressed in 
odds ratio, p-value and the confidence interval.  The p-value was set at a significant level 
<0.05.  For all values less than 5, the Chi square test was not sensitive to pick up differences, 
thus the Fisher’s Exact test was used to determine p-values (age-group, educational level, 
sexual debut, contraceptive method and pregnancies).  
3.14 LIMITATIONS OF THE STUDY 
This study enrolled women who were recruited from the district family planning and 
immunisation clinics and participating in the Microbicide clinical trial. These women had to 
fulfil a certain criteria to be randomised to the Microbicide clinical trial. Some of the basic 
enrolment criteria used was: They had to be HIV negative, non-pregnant, sexually active (at 
least 2 sex acts in a week), willing to receive condom use counselling, age 18 years and 
above, willing to attend clinic for scheduled follow-up visits, etc. Information and selection 
bias might have occurred as women were recruited from primary health care clinics, so this 
study might have underestimated patients who never sought care and those who normally 
seek care from other providers.  The researcher initially planned to recruit and enrol 120 
participants.  However, due to time constraints, the final sample size was 69 participants.  
Logistical issues of limited time negatively influenced the sample size. The small sample size 
may have masked real differences between the groups that could not be detected due to very 
wide confidence intervals in some analyses. As a result of the small sample size the results 
could not be generalised to the population. 
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3.16 SUMMARY 
In this chapter a comprehensive description of the research design, sampling procedure, data 
collection technique, data management and analysis methods have been explicitly presented.  
Data obtained from these analyses will be presented in the next chapter.  
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CHAPTER 4:  
ANALYSIS AND PRESENTATION OF THE RESULTS 
4.1 INTRODUCTION 
The results of the research project exploring the knowledge, awareness and perceptions of 
women on cervical cancer and screening, and also determining associated factors are reported 
in this chapter.  The results of the analyses are presented per study objective and described in 
tables where stated.  The sample size for the analyses was 69 women. 
4.2 SOCIO-DEMOGRAPHIC CHARACTERISTICS 
Table 4.1: Age-Group in women enrolled in cervical cancer study in rural KwaZulu-Natal n=69 
Age group Response n=69 % 
30-34 25 10.1 
35-44 25 36.2 
45-59 37 53.4 
Total 69 100% 
 
This study enrolled women from age 30 and above.  The age of the women ranged from 30 to 
59 years (Table 1), with a mean age of 44.5 years (Standard Deviation: 7.34).  
Table 4.2: Educational Status in women enrolled in cervical cancer study in rural KwaZulu-
Natal n=69 
Education Responses   n % 
No education 18 26.0 
Primary education 35 50.7 
Secondary/Higher 16 23.0 
Total 69 100% 
 
About a third of the sample, n=18 (26.09%) had no education, while n=35 (50.7%) had 
primary education and n=16 (23.19%) had secondary or higher education (Table 2).  
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Table 4.3: Employment status in women enrolled in cervical cancer study in rural KwaZulu-
Natal n=69 
Employment Responses    n % 
Unemployed 51 73.9 
Employed 18 26.0 
Total 69 100% 
 
According to table 3 most of the respondents n=51 (73.9%) were unemployed, while only 
n=18 (26%) were employed. 
Table 4.4: Monthly Earnings in women enrolled in cervical cancer study in rural KwaZulu-
Natal n=18 
Earnings Responses    n % 
R500 or less 11 61.1 
R1000-R2000 2 11.1 
R3000 + 1 5.5 
Refused to disclose 4 22.2 
Total 18 100% 
 
About two thirds of the sample were unemployed n=51 (73.9%) and n=18 (26.1%) were 
either employed full-time, part-time or self-employed.  Of those who were employed, 
n=1(5.9%) was earning R3000 and above, and n=2 (11.8%) were earning between R1000 and 
R2000.  The majority were earning R500 or less n=11 (35.3%) while n=4 women (23.5%) 
refused to disclose their monthly earnings (Table 3 & 4).  
Table 4.5: Sexual debut age in women enrolled in cervical cancer study in rural KwaZulu-Natal 
n=67 
Sexual debut Responses    n % 
<=15 Years 9 13.4 
16-19 36 53.7 
20+ 22 32.8 
Total 67 100% 
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Sexual initiation was reported as age 15 or less by n= 9 (13.4%) women, while more than half 
n=36 (53.7%) of the sample reported sexual initiation between 16 and 19 years of age.  Only 
n=22 (33%) reported sexual debut from 20 years of age and above (Table 5). Two women did 
not disclose their sexual debut age. 
Table 4.6: Marital status in women enrolled in cervical cancer study in rural KwaZulu-Natal 
n=69  
Marital Status Responses     n % 
Married 39 56.5 
Single 30 43.4 
Total 69 100% 
 
Just above half of the sample were married n=39 (56.5) and n=30 (43.5%) were single (Table 
6).  
Table 4.7: Previous pregnancies in women enrolled in the cervical cancer study in rural 
KwaZulu-Natal n=69 
Pregnancies(Gravid) Responses    n % 
None 2 2.8 
1-3 17 24.6 
4-5 22 31.8 
5+ 28 40.5 
Total 69 100% 
 
Only n=2 (2.9%) of the sample had never given birth, whilst n=28 (40.6%) reported five or 
more births (Table 7). 
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Table 4.8: Contraception in women enrolled in the cervical cancer study in rural KwaZulu-
Natal n=49 
Contraceptive method Responses    n % 
Condom 10 20.4 
Injectable 16 32.6 
Pills 9 18.3 
Sterilised 14 28.5 
Total 49 100% 
 
The majority of women were on contraceptives, n=49 (71.0%) and only n=20 (28.9%) were 
not using any method of contraceptives.  The most commonly reported method of 
contraception was injections (Depo provera / Nur Isterate) n=16 (32%)  (Table 8). 
4.3 THE EXTENT/LEVEL OF SCREENING FOR CERVICAL CANCER AMONG 
WOMEN AGED 30 YEARS AND ABOVE IN RURAL KWAZULU-NATAL 
Table 4.9: The report of previous screening for cervical cancer characterized per socio-demographic 
characteristics in rural women (69) aged 30 years and above enrolled in the study. 
N=69 Frequency Ever been screened P- value 
  No Yes  
Age group 
30-34 
35-44 
45+ 
 
  7 (10.1%) 
25 (36.2%) 
37 (53.4%) 
 
3(5.4%) 
23 (41.0%) 
30 (53.6%) 
 
4 (30.8%) 
2 (15.4%) 
7 (53.8%)       
 
0.012 
 
Marital status 
Married 
Single 
 
39 (56.5%) 
30 (43.4%) 
 
31 (55.4%) 
25 (44.6%)  
 
8 (61.5%) 
5 (38.5%) 
 
0.69 
Educational  
None 
Primary 
Secondary+ 
 
18 (26.0%)  
35 (50.7%) 
16 (23.0%) 
 
16 (28.6%) 
28 (50.0%) 
12 (21.4%) 
 
2 (15.4%) 
7 (53.8%) 
4 (30.8%) 
 
0.61 
 
 
30 
 
 
Sexual Debut* 
N=67 
<=15 years 
16-19 years 
20 and above 
 
  9 (13.4%)
  
36 (53.7%) 
22 (32.8%) 
 
8 (14.8%) 
28 (51.9%)
  
18 (33.3%) 
 
1 (7.7%) 
8 (61.5%) 
4 (30.8%) 
 
 
0.91 
* 2 values 
missing 
 
Family Planning 
None  
Yes 
 
20 (28.9%) 
49 (71.0%) 
 
14 (25.0%) 
41 (75.0%) 
 
6 (38.5%) 
8 (61.5%) 
 
0.33 
Contraception  
method N=49 
Condom 
Injectable 
Pills 
Sterilized 
 
 
10 (20.4%)
   
16 (32.6%) 
  9 (18.3%) 
14 (28.5%) 
 
 
7 (17.1%) 
16 (39.0%) 
6 (14.6%) 
12 (29.3%) 
 
 
3 (37.5%) 
0 (0) 
3 (37.5%) 
2 (25.0%) 
 
 
0.04 
Gravid 
(Pregnancies) 
None 
1-3 
4-5 
5+ 
 
2 (2.8%) 
17 (24.6%) 
22 (31.8%) 
28 (40.5%) 
 
2 (3.6%) 
11 (19.6%) 
18 (32.1%) 
25 (44.6%) 
 
0 (0) 
6 (46.2%) 
4 (30.8%) 
3 (23.0%) 
 
0.196 
Employment 
Unemployed 
Employed 
 
51 (73.9%) 
18 (26.0%) 
 
44 (78.6%) 
12 (21.4%) 
 
7 (53.9%) 
6 (46.1%) 
 
0.22 
 
Out of the 69 women enrolled in this study, only n=13 (18.8%) reported having ever been 
screened for cervical cancer in their lifetime, and n=56 (81.1%) of the sample had never 
screened for cervical cancer.  The sample was comprised of women from age 30 and above, 
above half n=37 (53.6%) of women aged 45 years and above had never been screened for 
cervical cancer, the p-value suggests a significant statistical difference (p=0.012).  A greater 
proportion of married women n=8 (61.5%) reported having been screened for cervical cancer 
compared to n=5 (38.5%) for single women.  Half of women with primary education n=28 
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(50.0%) had never been screened, however just above half n=7 (53.8%) reported ever been 
screened.  Only n=2 (15.4%) women with no education reported ever been screened for 
cervical cancer.  The greater proportion of women who reported sexual initiation between 16-
19 years had never been screened n= (51.9%) while n=8 (14.8%) of the sample who reported 
sexual initiation as age 15 or less had never been screened.  A third of women who reported 
sexual initiation from age 20 and above had never been screened n=18 (33.3%).  Just above 
half n=8 (61.5%) of women who reported family planning had ever been screened, compared 
to a third n=6 (38.5%) of the sample who were not on any form of contraception.  None of the 
women using injectable contraceptives had ever been screened.  Women who were using 
other forms of contraceptives reported previous screening in almost proportional percentages, 
condoms n=3 (37.5%), pills n=3 (37.5%) and sterilization n=2 (25.0%). The p-value=0.04 
suggests a significant statistical difference in the groups.  The proportion of ever being 
screened for cervical cancer was almost half n=6 (46.2%) in women who reported 1-3 
pregnancies and decreased with increasing number of pregnancies, 4-5 pregnancies n=4 
(30.8%) and 5+ pregnancies n=3 (23.0%).  The reports of prior screening per employment 
status was almost equal, unemployed n=7 (53.9%) and employed n=6 (46.1%).  Reporting of 
prior screening for cervical cancer characterized per socio-demographic factors is shown in 
table 9. 
4.4 FACTORS ASSOCIATED WITH BEING SCREENED FOR CERVICAL 
CANCER IN  WOMEN AGED 30 YEARS AND ABOVE 
Table 4.10: Factors associated with having been screened for cervical cancer in women aged 30 
years and above in rural KwaZulu-Natal  
N=69 Ever been screened: Odds Ratio  
[95% CI] 
p-value Adjusted odds ratio      
CI 
 No                Yes                   
Age group      
30-34 3   (5.4%) 4 (30.8%) 1   
35-44 23 (41.0%) 2 (15.4%) 0.06 [0.008-0.52] 0.01 0.09    [0.010-0.79] 
45+ 30 (53.6%) 7 (53.8%) 0.05 [0.03-0.97] 0.05 0.12    [0.03-1.49] 
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Marital status     
Married   31 (55.4%) 8 (61.5%) 1   
Single 25 (44.6%) 5 (38.5%) 0.78 [0.23-2.27] 0.69  
Educational level     
None 16 (28.6%) 2 (15.4%) 1   
Primary 28 (50.0%) 7 (53.8%) 2.0   [0.37-10.8] 0.42  
Secondary+ 12 (21.4%) 4 (30.8%) 2.67 [0.42-17.05] 0.30  
Sexual debut     
<=15 years 8 (14.8%) 1   (7.7%) 1   
16-19 years 28 (51.9%) 8 (61.5%) 2.29 [0.25-21.09] 0.47  
20 and above 18 (33.3%) 4 (30.8%) 1.78 [0.17-18.53] 0.63  
Employment      
Unemployed 44 (78.6%) 7 (53.9%) 1   
Employed 12 (21.4%) 6 (46.1%) 3.14 [0.89-11.1] 0.07  
 
The researcher was assisted by the Stellenbosch statistician to analyse data in SAS statistical 
programme using Fisher’s Exact Test to explore significant differences in the two groups, 
women who ever screened for cervical cancer and those who had never screened for cervical 
cancer.  When comparing women who had reported having been screened for cervical cancer 
to women who had never been screened, Table 10, the only factor that was significantly 
associated with screening was age in univariate analyses.  Older women aged 35 to 44; 45 and 
above were significantly less likely than women aged 30 to 34 years to screen for cervical 
cancer (OR: 0.06; 95% CI: 0.008-0.52), and women aged 45 years and above (OR: 0.18; 95% 
CI: 0.03-0.97).  Single women were less likely than married women to go for cervical cancer 
screening, but this difference was not statistically significant.  The level of education achieved 
seemed to increase the likelihood to screen, twice if a woman had primary education (OR 2.0) 
and almost 3 times (OR 2.67) if a woman had secondary and higher education; however this 
difference was not statistically significant.   
Employed women were 3 times more likely to screen for cervical cancer compared to 
unemployed women, but the difference was not statistically significant (p=0.07).  Other 
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factors considered but not presented as they contained values more than 1 were contraception 
and gravid.  In multivariate analysis factors with a p-value of 0.1 or less were considered.  
Women aged 35 to 44 remained significantly less likely than women 30 to 34 years to screen 
for cervical cancer (aOR 0.09; 95% CI: 0.10-0.79).  The result of factors associated with 
previous screening for cervical cancer is presented in Table 10. 
4.5 KNOWLEDGE, PERCEPTION AND ATTITUDES ON CERVICAL SCREENING 
AND  CERVICAL CANCER OF WOMEN AGED 30 YEARS AND ABOVE 
4.5.1 Knowledge about cervical cancer and the main source of information 
Table 4.11: Cervical cancer description by women aged 30 years and above enrolled in the study 
survey in rural KwaZulu-Natal n=69 
Cervical  Cancer description n % 
Could not give a cancer description 22 32% 
Bad/fatal disease of the uterus curable if diagnosed  early 22 32% 
Sores or growths in the uterus 13 19% 
Irregular/heavy per vaginal bleeding 10 14.5% 
Lower abdominal pain or per vaginal discharge 2 2.9% 
Caused by having multiple sexual partners 1 1.4% 
Know disease but has never seen someone affected 1 1.4% 
 
A greater percentage of the sample reported having information on cervical cancer and 
screening n=63 (91.3%).  However, when asked to describe cervical cancer n=22 (32%) of the 
respondents could not.  Of those who had some information about cervical cancer, a greater 
percentage n=22 (32%) of respondents gave a general description of a bad disease or fatal 
disease of the uterus which is curable when diagnosed early. Responses given on the 
description of cervical cancer are presented in table 11. 
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4.5.2 The main source of cervical cancer information 
 
Figure 4.1: The main source of cervical cancer information reported by women enrolled in the 
cervical cancer study in rural KZN. 
The main source of information was obtained at the clinics (district and MDP clinics) n=38 
(60.3%), some got information from the media n=14 (22%), hospital or private doctors n=6 
(10%), relatives or friends n=3 (5%) and community or neighbours n=5 (8%).  Only one (2%) 
who responded mentioned posters as the source of cervical cancer information (Fig 1.)  
4.5.3 Cervical cancer risk factors, screening and prevention 
Table 4.12: Knowledge of cervical cancer risk factors, screening and prevention by women aged 
30 years and above, enrolled in the cervical cancer survey in rural KwaZulu-Natal   n=69 
Variables Responses n % 
Have information on 
cervical screening 
No 
Yes 
  6 
63 
10.7% 
89.2% 
Cervical cancer 
screening test 
Don’t know 
Blood 
Pap smear 
Urine 
  7 
  2 
48 
  2 
24% 
2.9% 
69.5% 
2.9% 
Risk factors 
knowledge 
Sufficient answers (3 correct responses) 
No/wrong answers 
Insufficient answers (one or two correct)  
  4 
40 
25 
24% 
57.9% 
36.2% 
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cervical cancer 
preventable 
Yes 
Don’t know 
No 
42 
21 
  6 
60.9% 
30.4% 
8.7% 
Prevention methods 
n=42 
Early screening/management 
Treating STIs 
Protected sexual intercourse 
Surgical removal of the affected part 
28 
 6 
 5 
 3 
66.7% 
14.2% 
12.0% 
7.1% 
Frequency of 
cervical cancer  
screening 
Every 2 years 
Every 6 months 
Yearly 
monthly 
3 times in a lifetime from age 30 
  5 
33 
14 
15 
  2 
7.25% 
47.8% 
20.3% 
21.7% 
2.9% 
Total  69 100% 
 
When asked to give at least three risk factors for cervical cancer, only n=4 (5.8%) gave 
sufficient and correct answers.  More than half of the sample n=40 (57.9%) did not give a 
single response or else gave wrong responses.  About a third gave one of the three required 
responses n=25 (36.2%).  The most commonly stated risk factors were: early sexual debut 
n=18 (62%), smoking n=8 (28%), untreated sexually transmitted infections n=15 (52%), 
multiple births n=10 (34%).  None of the respondents mentioned HPV as a risk factor.  Others 
cited signs of invasive cancer as risk factors, for an example heavy or irregular menses and 
offensive vaginal discharges. 
When asked about a cervical cancer screening test n=17 (24.6%) did not know, however, 
above half n= 48 (69.5%) knew a Pap smear screening test.  Just a few mentioned blood and 
urine as cervical cancer screening tests, 2 (2.9%) respectively. Only n=2 (2.9%) knew that 
women should at least screen 3 times in their lifetime from age 30.  Almost half n=33 (47.8%) 
thought women should screen every 6 months, yearly n=14 (20.3%), or every 2 years n=5 
(7.25%).  Some thought women should screen for cervical cancer monthly or every 3 months 
n=15 (21.7%).  
Above half of the sample n=42 (60.9%) knew that cancer of the cervix can be prevented, 
n=21 (30.4%) did not know and n=6 (8.7%) said it cannot be prevented. Of those who knew it 
can be prevented, a greater percentage correctly stated that early screening (Pap smear) and 
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early management can prevent cervical cancer n=28 (66.7%).  Other preventive measures 
stated were treating sexually transmitted infections, protected sexual intercourse, and surgical 
removal of the affected part. Data is tabulated in Table 12. 
4.5.4 Cervical cancer screening perceptions and knowledge thereof 
Table 4.13: Cervical cancer screening perceptions and women’s knowledge thereof enrolled in 
the cervical cancer study in rural KwaZulu-Natal n=69 
Variables Responses N % 
Perceives self at risk No 
Yes 
27 
42 
39.2 
60.8 
Ever been screened 
for cervical cancer 
No 
Yes 
56 
13 
82 
18 
Reasons for not 
screening 
Did not have information 
Told procedure painful 
Too embarrassed to expose private parts  
48 
6 
2 
85.7 
10.7 
  3.5 
Intention to screen 
in the future  
No 
Yes 
5 
64 
7 
93 
Reasons for 
unwillingness to 
screen for cervical 
cancer in the future 
Told had no cancer 
Had a hysterectomy performed 
Felt the procedure was too embarrassing 
2 
2 
1 
40 
40 
20 
Ideal screening 
centre/institution 
District clinics 
Hospital 
Private doctor 
46 
13 
  5 
72 
20 
 7.8 
 
Above half of the sample n=42 (60.8%) considered themselves to be at risk of cervical cancer, 
however n=27 (39.2%) did not.  Despite a greater percentage perceiving themselves at risk 
only n=13 (18.8%) had ever been screened in their lifetime and n=56 (81.1%) had never been 
screened.  The reasons that were given for not screening previously was that they did not have 
information n=48 (85.7%) and n=6 (10.7%) were told the procedure is painful.  Others were 
too embarrassed to expose their private parts n=2 (3.5%).  Only one cited negative attitudes of 
health care providers as a barrier to screening.  Some women thought one should only screen 
when one has symptoms.  Of those who screened previously no negative attitudes or 
experiences were reported except for one who reported not receiving results following a 
screening test.  Intentions for future screening were established and almost all but five women 
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were willing to test n=64 (93%).  The most common service provider sited as ideal was the 
district clinic.  Women who had no intention to screen in the future gave various reasons.  
They said they had a hysterectomy performed n=2 (40%); they said they were told that they 
had no cancer n=2 (40%); one felt the procedure was too embarrassing n=1 (20%)  (Table 
13). 
4.6 SUMMARY 
In chapter four the socio-demographic characteristics of women who enrolled in the cervical 
cancer awareness and knowledge study and also instances reflecting cervical screening history 
have been described.  The extent/level of cervical cancer screening and associated factors 
have also been explained.  The analysis showing factors associated with having had screening 
for cervical cancer versus never having had screening has also been described.  Finally, a 
description of knowledge, perceptions and attitudes has been presented and described.  The 
next chapter will have a discussion of findings, including an explanation of overarching 
factors and implications where appropriate, the conclusion drawn and recommendations 
suggested. 
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CHAPTER 5:  
DISCUSSION AND RECOMMENDATIONS 
5.1 INTRODUCTION  
The study was aimed at determining factors influencing access to cervical screening services 
and utilization of such services.  Knowledge and perceptions of women on cervical cancer and 
screening and socio-demographic characteristics influencing screening were also determined 
and characterized.  This chapter discusses findings of the study, the extent to which they may 
be generalizable, the limitations of the study and recommendations are subsequently 
suggested.  The discussion is presented in three sections according to the objectives of this 
study, namely socio-demographic characteristics, the rate of screening for cervical cancer and 
factors associated with previous screening for cervical cancer and knowledge, and perceptions 
on cervical cancer and screening. 
5.2 FINDINGS  
5.2.1 Socio-demographic characteristics of women 
The sample for the analyses included n=69 women from age 30 and above. Although this is a 
small sample size, it is not inconsistent with demographic and socio-economic data that has 
been previously reported in this rural geographic area. The sample comprised mainly middle 
aged women since the study exclusively enrolled women from age 30 and above.  This age 
group is consistent with age intervals as laid down in the National cervical screening 
programme (Moodley, 2009:11). More than half n=51 of the sample had some form of 
education, though almost half of the sample had only achieved primary education.  The 
greater proportion of women were unemployed, however, this factor could not have hindered 
women from accessing district health services for screening since the services are provided 
free of charge.  
The employment rate was also very low, with only n=18 (26%) of women being employed 
either part-time or full-time.  However, the analyses included a high sample of unemployed 
women, although this may be expected given that the microbicide study clinics were primarily 
open during work hours.  This high unemployment rate is a course for concern and reflects a 
challenge in reaching the millennium target of achieving permanent and decent work for all, 
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including women, and also halving the proportion of people who suffer from hunger by 2015.  
This could negatively impact on access to health care services (including cervical screening 
services), especially where women are required to pay transport fees. Contrary to expectations 
it was encouraging to note that over half of these women (71%) were accessing 
contraceptives. This high proportion might have been influenced by participation to the 
Microbicide clinical trial, where women were strongly counselled to use contraceptives.  The 
goal of achieving universal access to reproductive health by 2015 is possible, given the high 
contraceptive prevalence in this rural population (KwaZulu-Natal health website, Millennium 
Development Goals (MDG) indicators, 2008). 
5.2.2 The rate of screening and factors associated with having been screened 
for cervical cancer  
Despite a greater percentage (60.8%) of women perceiving themselves at risk of cervical 
cancer, a very low percentage (18.8%) had ever been screened in their lifetime.  Research 
conducted in other countries have shown similar results, in most cases women thought one 
needs to go for a test as a result of  a recommendation by a  health professional (Adanu, 
2002:487-488; Ezem, 2007:95). Moodley (2009) re-iterates that, in reality women in 
developing countries usually attend health care for cervical smear when the disease is 
symptomatic and progressed to advanced stages.  Both women and health care workers attest 
to women accepting cervical cancer screening when they are symptomatic as opposed to a 
health screening test (Wood & Jewkes, 1996:10; Leyden, Manos, Geiger, Weinmann, 
Mouchawar, Bischoff, Yood, Gilbert and Taplin, 2005:677; and Hoque, Hoque and Kader, 
2008:112).  The research studies have shown a high HIV incidence in this rural KwaZulu-
Natal population 3.4 per 100 person-years from the years 2003-2007 (Bärnighausen, Tanser 
and Newell, 2009:406), and the risk of cervical cancer is also high. However, the cervical 
screening frequency does not correlate to the risk.  The cervical cancer screening frequency 
also needs to be revised especially for HIV exposed and infected women since the literature 
suggests that disease progression to invasive cancer usually occurs ten years earlier in HIV 
positive women (Health Systems Trust, 2009:1; Franceschi & Jaffe, 2007:511). 
There are very few differences between women who had been or had never been screened for 
cervical cancer.  This is possibly indicative of a generalized low utilization of cervical 
screening in this population especially in relation to low awareness levels on cervical cancer 
and screening in KwaZulu-Natal.  There was a greater concordance among the various local 
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studies in the low cervical screening rates in women (Abrahams, Wood & Jewkes, 1996:22; 
Moodley, 2009:12).  A study conducted in KwaZulu-Natal did not find any significant 
predictor for doing a Pap smear among respondents; however this study was conducted 
among university students (Hoque & Hoque, 2009:22). This may be indicative of a general 
awareness, knowledge and access problem irrespective of educational background.  
Women with lower socio-economic status were less likely to go to clinics for screening for 
cervical cancer, although this difference was not statistically significant. This raises concerns 
since government primary health care services are provided free of charge.  It is not clear 
whether this is linked to perceptions in the community about free health services, and 
addressing this might shed some light on reasons for this relationship.  Older women between 
the ages 35-44 were less likely to screen for cervical cancer compared to younger women.  
Leyden et al., (2005) found similar results.  This is of great concern since at these ages 
women should at least have received a second Pap smear (according to the National screening 
programme).  According to Abrahams et al., (1996: 8), “early screening services focused on 
family planning attenders and women using antenatal services”.  Even when considering this 
earlier focus, with more than half n=49 (71%) of the sample reporting using family planning, 
one would expect that a greater proportion of women were reached with this educational 
information at some stage.  Evidence from prior research indicates that hearing about cervical 
screening does not always translate to higher usage of the screening service (Adanu, 
2002:487; Twinn, Shiu and Holroyd, 2002:382; Abrahams, Wood and Jewkes, 1996:12; 
Hoque, Hoque and Kader, 2008:113).  There should be a considerable amount of packaging 
messages in line with the target population coupled with re-enforcement of messages.  The 
focus should be on all women receiving comprehensive health services including screening 
for cervical cancer. This study recruited women who were already utilizing primary health 
care services, therefore one would expect the utilization for cervical screening to be higher 
than the result presented.  
The odds of cervical screening were less in single women compared to married women.  
Studies conducted elsewhere have shown a significant difference of cervical screening and 
marriage, with married women more likely than single women to screen for cervical cancer 
(Twinn et al., 2002:379; Leyden et al., 2005:677).  This could be attributed to differences in 
risk perceptions by marital status.  In other studies women explained the role played by 
marital partners as vital to the utilizing of screening (Twinn et al., 2002:380; Ezem, 2007:95). 
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Wong et al., (2009) also reported that married women had a higher recognition of cervical 
cancer risk factors than unmarried women.  The health educational initiatives on cervical 
cancer should not only target women since male partners have a potential of playing a vital 
role in increasing utilization of this service. 
5.2.3 Knowledge and perceptions of women on cervical cancer and screening 
Women who were enrolled in this study were exposed to some education on cervical cancer 
screening, since this service was provided as standard of care to all Microbicide clinical trial 
participants.  Despite this exposure, the level of knowledge was still low in this group.  A 
greater proportion of women who had never tested cited lack of awareness as the main reason.  
According to Moodley (2009:11-12), the main barriers to testing in developing countries are a 
lack of awareness of the disease and screening, women not availing themselves of screening 
services and lack of political will to provide the service.  Dissemination of information should 
focus on all women especially eligible women (aged 30 years and above in the South African 
context).  Women seem to remember messages re-enforced, this is evidenced by more than 
two thirds (n=15) of women stating that the Pap smear should be conducted every three 
months.  Women in this cohort were screened for sexually transmitted infections (STIs) every 
three months through pelvic examination and cervico-vaginal sample collection.  There is a 
possibility that the Pap smear cervical cancer screening test, which was conducted once at 
enrolment, was confused with the three monthly screening for STIs that were conducted as 
part of the microbicide clinical trial procedures.  This indicates that re-enforcement of positive 
and correct messages could be helpful to motivate women to screen for cervical cancer.  It is 
of vital importance to carefully package cervical cancer and screening messages and also to 
ensure that the wider female population is reached.  Lyttle and Stadelman (2006:6), also 
found uncertainty on the frequency of cervical screening tests with women reporting that 
cervical screening should be performed six monthly.  The basic screening test was known by 
more than half of the sample, however it is worrying to note that despite women having been 
exposed to the same screening test, still almost 30% did not know the basic cervical cancer 
screening test.  Earlier studies conducted in the same rural population found similar results 
(Wood & Jewkes, 1996:9). There is a great need to empower women to understand their 
health care needs and also basic screening procedures so as to increase the uptake of this 
service. 
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It was encouraging to learn that a greater proportion of women received cervical cancer 
information from the clinics or community health workers. Hogue and Hogue, (2009:22); 
Ezem, (2007:95); Abrahams et al., (1996:29); Lyttle and Stadelman, (2006:3) found similar 
results. Conversely, Wong, Wong, Low, Khoo and Shuib, (2009) reported that lack of 
recommendation by health care providers hindered women in screening for cervical cancer.  
In addition, preventive counselling to reduce the risk of cervical cancer is viewed as of less 
importance by health professionals in other settings (Tessarro, Herman, Shaw and Giese, 
1996:272).  Only one woman stated that she got cervical cancer information from the posters.  
This further intensifies the need for all health care professionals who come into contact with 
women to include cervical cancer and screening information in the health talks.  Women 
showed lack of understanding of the basic female anatomical parts; they vaguely described 
cervical cancer as a bad and fatal disease without mentioning the cervix.  Wood and Jewkes 
(1996:16) found similar results in earlier studies conducted in this population.  It is important 
to explore terminology used by women to refer to female parts, adjust and use these in the 
health educational talks.  
Lack of sufficient knowledge was demonstrated by more than half (57%) of women not 
knowing risk factors for cervical cancer.  The danger of not knowing risk factors is that 
chances of prevention of behavioral risk factors are almost non-existent.  This then results in a 
greater proportion of women at risk of cervical cancer.  Literature reports that HPV is a 
significant risk factor for cervical cancer (Khan, Castle, Lorincz, Wacholder, Sherman, Scott, 
Rush, Glass and Schiffman, 2005:1073; Chirenje et al., 2002:766).  The same premise may 
apply about ignorance on whether cancer can be prevented or not.  This study showed that 
women knew that cancer could be prevented.  Women (60%) of the sample also correctly 
stated that cervical cancer could be prevented through early screening and management. This 
would form a basis for motivating women to screen for cervical cancer. Willingness to screen 
in the future was also a strong factor in this sample. Conversely, in other populations, lack of 
willingness to test is attributed to perceived lack of personal susceptibility to cervical cancer 
(Wong et al., 2009:50).  Lyttle and Stadelman (2006:4), reported misconceptions for future 
screening like a previous hysterectomy regardless of the reason.  There is need to scale up 
health education on cervical screening services and also access to such services so as to 
increase impact in reduction of cervical cancer incidence and mortality due to invasive cancer. 
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5.3 BIAS AND LIMITATIONS 
Information and selection bias might have occurred as women were recruited from primary 
health care clinics, so this study might have underestimated patients who never sought care 
and those who normally seek care from other services.  The HIV positive status was an 
exclusion criterion for enrolment to the Microbicide clinical trial from which the sample for 
this study was drawn.  It was, therefore, not possible to explore whether there are any 
differences in knowledge and perception levels in women who are HIV positive.  The current 
national screening guideline does not discuss frequency of screening for HIV positive women.  
This should be included and also communicated to the wider population so as to correct 
misconceptions around cervical cancer.   
The researcher aimed to enrol 120 women in this study, but due to time constraints ended up 
with a sample of 69 respondents.  However, this sample is representative of the women 
eligible for cervical screening as per the National cervical screening policy. The non-
probability convenience sampling might have decreased the samples’ representativeness of 
the population and also offered little opportunity to control for biases.  The small sample size 
may well have masked real differences between the groups that could not be detected due to 
very wide confidence intervals in some analyses.  The weakness of this analysis is that the 
sample is small and results cannot be generalizable to other populations in which studies on 
cervical cancer knowledge and perceptions are conducted. 
5.4 CONCLUSION AND RECOMMENDATIONS 
The sample for this study was drawn from women who were participating in the Microbicide 
clinical trial in which cervical screening was offered as a standard of care. However, this 
study revealed that there is limited information about cervical cancer, risk factors and cervical 
screening among this population.  Also these results suggested poor dissemination of 
information by health care professionals.  Women in rural populations rely mostly on health 
care professionals to educate and recommend health care practices that are beneficial in terms 
of health promotion.  Women stated lack of information as the main barrier to screening; most 
surprisingly these women were recruited from health care services.  Cervical screening 
initiatives should aim to reach women who have never had a Pap smear done and all eligible 
women.   
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Information pamphlets or posters should be user friendly i.e. translated to the local language 
and also distributed to the female population as widely as possible.  The health managers 
should review packaging of information so as to simplify complex terminology when 
necessary to enhance understanding by all women.  The use of audio-visual aids presented in 
the local language (for example video clips in clinic/hospital waiting rooms) should be 
reinforced.  Cervical cancer and screening messages should form part of the basic health 
education package offered to all women, irrespective of their health status.  Mini surveys 
should also be periodically conducted to elicit the level of understanding on cervical cancer 
and the importance of screening.  Information obtained would then assist health professionals 
to further improve the screening services.  
The national screening guideline should be revised to include cervical cancer screening in 
HIV positive women, and also resources should be scaled up in line with the HIV prevalence 
in this population.  This should be coupled with staff training and periodic in-service 
education, but also revision of basic health programs would also be necessary.  Health 
educational initiatives should also target men since studies suggest that male partners could 
play a vital role in increasing the awareness of this service.  It is recommended that further 
large scale studies be conducted to focus on exploring health care resources that influence 
access across the district so as to better understand reasons for the low uptake of the screening 
service in this rural community. 
5.5 CONCLUDING REMARK  
Most of the women in this study had never been screened for cervical cancer in their lifetime 
as reflected by n=14 (18%) ever screened and n=55 (82%) never screened for cervical cancer 
in this study. The results of this study cannot be generalised to the population due to the small 
sample size.  However, there a need to re-inforce a comprehensive health education and 
cervical screening programme to target women in rural communities and to ensure the success 
of the cervical screening programme. The results of this study showed that 60% of 
respondents were informed by health care professionals on cervical cancer screening. Health 
care workers also should play a vital role in educating communities on cervical cancer and on 
the benefits for cervical cancer screening, reaching all patients who utilise health care services 
with this information and also communities through outreach programmes.  Attempts should 
be made to reach women who rarely visit health care services, for example, through 
increasing health campaigns in partnership with other organizations in the area. 
45 
 
BIBLIOGRAPHY 
Abrahams, N., Wood, J. & Jewkes, R. 1996: Cervical Screening in Montagu District: 
Women’s experiences, coverage and barriers to uptake. Report: Cersa-Women’s Health 
MRC, Tygerberg. 
Adanu, R.M.K. 2002: Cervical Cancer Knowledge and Screening in Accra, Ghana. Journal of 
Women’s Health & Gender-based Medicine. 11(6), pp.487-488. 
American Cancer Society, 2009 Available at. http://www.cancer.org/docroot/CRI/content 
242X: Do we know what causes Cervical Cancer.2009. [Accessed 04 August 2009] 
Bärnighausen, T., Tanser, F. & Newell, M.L. 2009: Lack of a Decline in HIV Incidence in a 
rural Community with High HIV Prevalence in South Africa, 2003-2007. AIDS research 
and Human Retroviruses (Short communication). 25 (4), pp.405-409. 
Bayo, S., Bosch, X., de Sanjose, S., Munoz, N., Combita, A., Coursaget, P., Diaz, M., Dolo, 
A., van den Brule, A. and Meijer, C. 2002: Risk factors of invasive cervical cancer in Mali. 
International Journal of Epidemiology. 31, pp.202-209. 
Brink, H. 2006. Fundamentals of research methodology for health care professionals. 2nd 
Edition. Cape Town: Juta. 
Burns, N. & Grove, S. K. 2001: The practice of nursing research: conduct, critique and 
utilization. 4th Edition. Philadelphia: WB Saunders. 
Burns, N. & Grove, S. K. 2009: The Practice of Nursing Research: Appraisal, Synthesis and 
Generation of Evidence. 6th Edition. Philadelphia: WB Saunders. 
Cervical Cancer Health Guide: Can Cervical Cancer Be Prevented. 2008. 
http:/www.cancer.org/docroot/content/2_4_2X. Accessed 2009/08/05. 
Chirenje, Z.M., Rusakaniso, S., Kirumbi, L., Ngwalle, E.W., Makuta-Tlebere, P., Kaggwa, S., 
Mpanju-Shumbusho, W. & Makoae, L. 2001: Situational analysis for cervical cancer 
diagnosis and treatment in East, Central and Southern African countries. Bulletin of the 
World Health Organization. 79 (2), pp.127-132. 
46 
 
Chirenje, Z.M., Loeb, L., Mwale, M., Nyamapfeni, P., Kamba, M. & Padian, N. 2002: 
Association of cervical SIL and HIV-1 infection among Zimbabwean women in an 
HIV/STI prevention study. International Journal of STD & AIDS 13, pp.765-768. 
Department of Health, 2003: KwaZulu-Natal Epidemiology Bulletin, Epidemiology of chronic 
degenerative diseases in KwaZulu-Natal. 
Ezem, B.U. 2007: Awareness and Uptake of Cervical Cancer Screening in Owerri, South-
Eastern Nigeria. Annals of African Medicine. 6 (3), pp.94-98. 
Fisher, R.A. 1992: On the interpretation of ҳ² from contingency tables, and the calculation of 
P. Journal of the Royal Statistical Society 85(1): 87-94. 
Fitch, M., Greenberg, M., Cava, M., Spaner, D. & Karmel, R.N. 1998: Exploring the barriers 
to cervical screening in an urban Canadian setting. Cancer International Journal 21 (6), 
pp.441-449. 
Franceschi, S. & Jaffe, H. 2007: Cervical Cancer Screening of Women Living with HIV 
Infection: A Must in the Era of Antiretroviral Therapy. Clinical Infectious Diseases. 45, 
pp.510-513. 
Gerries, K. & Lacey, A. (Eds). 2006: The research process in nursing. 5th Edition. Oxford: 
Blackwell. 
Hawes, S.E., Critchlow, C.W., Faye Niang, M.A., Diouf, M.B., Aissatou, D., Touré, P., 
Kasse, A.Z., Dembele, B., Sow, P., Coll-Seck, A., Kuypers, J. & Kiviat, N. (2003). 
Increased Risk of High-Grade Cervical Squamous Intraepithelial Lesions and Invasive 
cancer among African Women with Type 1 and 2 Infections. Journal of Infectious 
Diseases 188, pp.555-563. 
Health Systems Trust. 2006: South African Health Review 2006.  
Health Systems Trust. Policy Brief 2. March 2009. Cervical Cancer and HIV: The intimate 
connection.  
Hoque, M. and Hoque, E. 2009: Knowledge of and attitude towards cervical cancer among 
female university students in South Africa. South Afr J Epidemiol Infect 24(1), pp.21-24. 
47 
 
Hoque, M., Hoque, E & Kader S. 2008: Evaluation of cervical cancer screening program at a 
rural community of South Africa. East African Journal of Public Health 5(2), pp.111-116. 
Katzenellenbogen, J.M., Joubert, G and Abdool-Karim, S.S. 1999: Epidemiology: A manual 
for South Africa, Cape Town: Oxford University Press. 
Kawonga, M & Fonn, S. 2008: Achieving effective cervical screening coverage in South 
Africa through human resources and health systems development. Reprod Health Matters. 
16(32), pp.32-40. 
Khan, M., Castle, P.E., Lorincz, A.T., Wacholder, S., Sherman, M., Scott, D., Rush, B., Glass, 
A. and Schiffman M. 2005: The Elevated 10-Year Risk of Cervical Precancer and Cancer 
in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of 
Type-Specific HPV Testing in Clinical Practice. Journal of the National Cancer Institute. 
97 (14), pp.1072-1079. 
Kjaer, S.K. 1998: Risk factors for cervical neoplasma in Denmark. APMIS Suppl. 80.1-41 
Abstract. 
Leyden, W.A., Manos, M.M., Geiger, A.M., Weinmann, S., Mouchawar, J., Bischoff, K., 
Yood, M., Gilbert, J. and Taplin A. 2005: Cervical Cancer in Women with Comprehensive 
Health Care Access: Attributable Factors in the Screening Process. Journal of the National 
Cancer Institute. 97(9), pp.675-683. 
Leroy, V., Ladner, J. De Clercq, A., Meheus, A., Nyiraziraje, M., Karita, E. and Dabis, F. 
1999: Cervical dysplasia and HIV type 1 infection in African pregnant women: a cross 
sectional study, Kigali, Rwanda. The pregnancy and HIV study Group (EGE). Sex. 
Transm. Inf. 75, pp.103-106. 
Lovejoy, N. 1996: Multinational approaches to cervical cancer screening: A review. Cancer 
Nursing an International Journal. 19 (2), pp. 126-134. 
Lyttle, N. & Stadelman, K. 2006: Assessing Awareness and Knowledge of Breast and 
Cervical Cancer among Appalachian Women. Preventing Chronic Diseases. Public Health 
Research, Practice, and Policy. 3(4), pp. 1-7. 
48 
 
Marteau, T.M., Hankins, M. & Collins, B. 2002: Perceptions of risk of cervical cancer and 
attitudes towards cervical screening: a comparison of smokers and non-smokers. Family 
Practice 19, pp. 18-22. 
Microbicide Development Programme, 2006: MDP Clinical Trial (Version 2.1): An 
International multicentre, randomized, double-blind, placebo-controlled trial to evaluate 
the efficacy and safety of 0.5% and 2% Pro2000/5 gels for the prevention of vaginally 
acquired HIV infection. “Microbicide development Programme Protocol”.  
Moodley, M. 2009: Cervical cancer in Southern Africa: The challenges. SA Journal of 
Gynaecological Oncology. 1, pp. 11-13. 
Department of Health: National guidelines on cervical cancer screening. 2000: South Africa. 
Oxford Concise English Dictionary. 1995: Oxford: University Press. 
Pocket Medical Dictionary. 2003: Oxford: Blackwell. 
Pollack, A.M., Balkin, M., Edouard, L., Cutts, F. and Broutet, N. 2007: Ensuring access to 
HPV vaccines through integrated services: a reproductive health perspective. Bulletin of 
the World Health Organization. 85, pp. 57-63. 
Polit, D.F., Beck, C.T. and Hungler, BP. 2001: Essentials of nursing research methods, 
appraisal and utilization 5th edition. Philadelphia: Lippincott. 
Ruche, G.L., Ramon, R., Mensah-Ado, I., Bergeron, C., Diomondé, M., Sylla-Koko, F., 
Ehouman, A., Touré-Coulibaly, K., Welffens-Ekra, C. & Dabis, F. 1998: Squamous 
Intraepithelial lesions of the cervix, Invasive cervical Carcinoma, and Immunosuppression 
Induced by Human Immunodeficiency Virus in Africa. Cancer 82, pp. 2401-2408 
Smeltzer, S.C. and Bare, B.G. 2004: Handbook for Brunner & Suddarths Texbook of 
Medical-Surgical Nursing 10th Edition. Philadelphia: Lippincott. 
Tate, D.R. & Anderson, R.J. 2002: Recrudescence of cervical dysplasia among women who 
are infected with the human immunodeficiency virus: A case-control analysis. Am J Obstet 
Gynecol 186, pp. 880-882. 
49 
 
Tessarro, I., Herman, C., Shaw, J. & Giese, E. 1996:  Cancer prevention knowledge, attitudes, 
and clinical practice of nurse practitioners in local public health departments in North 
Carolina. Cancer N and International Journal. 19(4), pp.269-274. 
Twinn, S., Shiu, A.T.& Holroyd, E. 2002: Women’s Knowledge about Cervical Cancer and 
Cervical Screening Practice: A pilot study of Hong Kong Chinese Women. Cancer 
Nursing, 25 (5), pp.377-384. 
Wong, L.P., Wong, Y.L., Low, W.Y., Khoo, E.M. and Shuib, R. 2009: Knowledge and 
awareness of cervical cancer and screening among Malaysian women who have never had 
a Pap smear: a qualitative study. Singapore Med J. 50 (1), pp.49-53. 
Wood, J and Jewkes, R. Cervical Screening in Hlabisa District: Women’s experiences and 
barriers to uptake. Report: Cersa-Women’s Health MRC, Tygerberg, 1996 
World Health Organization (WHO). 2006:  Comprehensive Cervical cancer Control: A guide 
to essential practice. WHO Library Cataloguing- in-Publication Data. 
WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information 
Centre). A Summary report on HPV and Cervical cancer statistics in South Africa.2007. 
[Accessed 28 August 2008]. Available at  http://www.who.int/hpvcentre.  
WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). 
Human Papillomavirus and Related Cancers in Africa. Summary Report 2009.[ Accessed 
23 March 2010]. Available at  www.who.int/hpvcentre. 
Official list of MDG indicators (effective 15 January 2008) [Accessed 04 April 2010]. 
Available at http://www.kznhealth.gov.za.  
50 
 
APPENDICES 
 
Appendix A: Questionnaire 
 
Title: Women’s awareness, knowledge and experiences regarding cervical cancer and cervical 
cancer screening in rural KwaZulu-Natal.  
 
Cervical cancer survey questionnaire 
Date filled:  /  /      
Screening number: 
       
Initials: 
    
Year of Birth/ Age: 
     
Trial number: 
       
 
Interviewer: Complete this CRF for participants aged 30 years and above ONLY.  Read all questions verbatim 
and allocate the correct answer from the selection. Translate to local language as appropriate. Boxed type is 
instructions to the interviewer. Type in italics is to be answered by the interviewer from the information provided 
by the volunteer.  
Section 1: Socio‐demographics 
 
1 
 
What is your marital status? 
 
 Married 
 
Single 
 
Divorced 
 
Widowed 
 
Other 
Specify________________ 
  
  
  
  
  
 
 
2 What is the highest standard of education attained?  
None 
 
Primary ( Grade1-7) 
 
Secondary (Grade 8-10) 
 
Completed Matric 
 
Completed tertiary 
 
Student 
 
  
  
  
  
  
  
 
 
(dd/mm/yyyy)
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Questionnaire continued… 
 
Title: Women’s awareness, knowledge and experiences regarding cervical cancer and cervical 
cancer screening in rural KwaZulu-Natal. 
 
 
 
3a 
 
How can you describe your employment status at present? 
 
Employed full-time 
 
Employed part-time 
 
Unemployed 
 
student 
 
Other 
Specify_______________ 
 
  
  
  
  
  
   
Q2b 
      
   
Q2b 
 
3b 
 
If answer to Q3a above is “yes” . How much do you earn per 
month? 
 
 
R500 and less 
 
R501-R1000 
 
R1001-R2000 
 
R2001-R3000 
 
More than R3000 
Specify_______________ 
 
  
  
  
  
  
 
 
 
4 
 
Are you on any method of contraception?  
 
 
Yes 
 
No 
 
  
  
 
 
Q4b 
Cervical cancer survey questionnaire 
Date filled:  /  /      
Screening number: 
       
Initials:
    
Year of Birth/ Age: 
     
Trial number: 
       
(dd/mm/yyyy
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4b 
 
If answer to Q4a”yes” specify method. 
 
Pills 
 
Injectable Depo 
 
Injectable Nur Isterate 
 
Sterilised (self or partner) 
 
Condom (male or female) 
 
Other 
 
Specify________________ 
  
  
  
  
  
  
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Questionnaire continued… 
 
Title: Women’s awareness, knowledge and experiences regarding cervical cancer and cervical 
cancer screening in rural KwaZulu-Natal.  
 
Section 2: Knowledge/ Awareness 
 
7 What do you understand by cervical cancer? ________________________
________________________
________________________
________________________
________________________ 
  
Cervical cancer survey questionnaire 
Date filled:  /  /      
Screening number: 
       
Initials:
    
Year of Birth/ Age: 
     
Trial number: 
       
5 Have you ever been pregnant?  
Yes 
 
No 
 
 
 
  
  
 
 
  5b 
Q6 
5b If answer to Q5 “yes” explain your parity.  
0 
 
1-3 
 
4-5 
 
Above 5 
  
  
  
  
 
 
 
6 How old were you when you first started sexual intercourse.  
Age ( specify) 
 
 
  
 
 
 
 
(dd/mm/yyyy
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8 
 
What basic test is conducted to screen for cervical cancer? 
 
Blood test 
 
Urine test 
 
Pap smear test 
 
Don’t Know 
  
  
  
  
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Questionnaire continued… 
 
Title: Women’s awareness, knowledge and experiences regarding cervical cancer and 
cervical cancer screening in rural KwaZulu-Natal.  
  
Cervical cancer survey questionnaire 
Date filled:  /  /      
Screening number: 
       
Initials: 
    
Year of Birth/ Age: 
     
Trial number: 
       
 
 
9 
 
Do you have information about cervical cancer screening?, 
if so where did you get the from information? 
 
 
 
                              Yes 
 
                               No   
 
 
 
If yes(Specify): 
_________________________
_____________________ 
  
  
 
 
 
10 
 
 
 
Mention at least 3 risk factors for cervical 
cancer___________________________________________
________________________________________________
________________________________________________
________________________________________________
_____________________ 
 
 
Answer correct /sufficient 
 
Answer insufficient 
 
Unable to judge 
  
  
  
 
 
11 
 
Can cervical cancer be prevented? 
 
Yes 
 
No 
 
Don’t Know 
 
 
  
  
  
 
 
Q11a 
11a If answer to Q11”yes” how? _________________________
_________________________
_________________________
_________________________
_________________________
_________________________
_________________________
_ 
 
 
 
 
 
 
 
 
 
 
 
(dd/mm/yyyy
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Questionnaire continued… 
 
Title: Women’s awareness, knowledge and experiences regarding cervical cancer and cervical 
cancer screening in rural KwaZulu-Natal.  
 
 
 
 
 
 
 
 
 
Cervical cancer survey questionnaire 
Date filled:  /  /      
Screening number: 
       
Initials:
    
Year of Birth/ Age: 
     
Trial number: 
       
 
12 
 
How often do you think women should screen for cervical 
cancer? 
 
6 monthly 
 
Yearly 
 
Every 2 years 
 
3 times in lifetime, from age 30 
Other, specify 
_________________________
_________________________
________________ 
  
  
  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Section 3: Perceptions and attitude 
 
  
 
 
 
13 
 
Have you ever screened for cervical cancer (prior to joining 
the trial)? 
 
 
 
 
Yes 
 
No 
 
 
 
  
  
 
 
(dd/mm/yyyy
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Questionnaire continued… 
 
Title: Women’s awareness, knowledge and experiences regarding cervical cancer and cervical 
cancer screening in rural KwaZulu-Natal.  
 
Cervical cancer survey questionnaire 
Date filled:  /  /      
Screening number: 
       
Initials:
    
Year of Birth/ Age: 
     
Trial number: 
       
 
 
13a 
If answer to 13 above is “no” give reasons. Tick all that apply 
 
No facilities available 
 
Did not have information 
 
Told procedure is painful 
 
Did not have time 
 
Other 
 
Specify_______________ 
 
___________________ 
 
 
  
  
  
  
  
 
 
 
13b 
 
If answer to Q13 above is “Yes” describe your experiences. 
 
 
 
Attitude of care provider   
negative and non-caring 
 
              Procedure painful   
 
Procedure embarrassing 
 
Results not received/explained 
 
Other 
Specify___________________
_________________________
_________________________
_________ 
 
Y/N 
  
  
  
 
  
   
 
(dd/mm/yyyy
58 
 
 
14 
 
Do you think you are at risk of cervical cancer? 
 
Yes 
 
 
No 
  
 
  
 
 
 
 
 
 
Questionnaire continued… 
 
Title: Women’s awareness, knowledge and experiences regarding cervical cancer and cervical 
cancer screening in rural KwaZulu-Natal.  
 
Cervical cancer survey questionnaire 
Date filled:  /  /      
Screening number: 
       
Initials: 
    
Year of Birth/ Age: 
     
Trial number: 
       
 
 
15 
 
Would you screen for cervical cancer in future? 
 
 
 
Yes 
 
No 
 
Don’t know 
 
 
  
  
  
 
 
Q15a 
Q15b 
 
15a If answer to Q15 “Yes” where would you go for the test?  
District Hospital 
 
Private Hospital 
 
District clinic 
 
Private clinic 
 
Private Doctor 
 
  
  
  
  
  
 
 
 
15b If answer to Q15b is “no” give reasons.  
_________________________
_________________________
_________________________
_________________________
_________________________
_________________________
_________________________ 
 
  
(dd/mm/yyyy
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_______ End of form________________ 
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Appendix B – Participant information leaflet and consent form 
 
TITLE OF THE RESEARCH PROJECT: Women’s awareness, knowledge and experiences 
regarding cervical cancer and cervical cancer screening in rural KwaZulu-Natal 
REFERENCE NUMBER:N08/08/206 
 
PRINCIPAL INVESTIGATOR: Beauty Hlengiwe Ndlovu 
 
ADDRESS: 3 Cooper Road, Empangeni, 3880 
 
CONTACT NUMBER: Work: 035 550 7655; Mobile: 072 268 2875 
You are being invited to take part in a research project.  Please take some time to read the 
information presented here, which will explain the details of this project.  Please ask the study 
staff or doctor any questions about any part of this project that you do not fully understand.  It 
is very important that you are fully satisfied that you clearly understand what this research 
entails and how you could be involved.  Also, your participation is entirely voluntary and 
you are free to decline to participate.  If you say no, this will not affect you negatively in any 
way whatsoever.  You are also free to withdraw from the study at any point, even if you do 
agree to take part. 
This study has been approved by the Committee for Human Research at Stellenbosch 
University and will be conducted according to the ethical guidelines and principles of the 
international Declaration of Helsinki, South African Guidelines for Good Clinical 
Practice and the Medical Research Council (MRC) Ethical Guidelines for Research. 
What is this research study all about? 
 This study will be conducted among 120 women enrolled in MDP301 clinical trial 
attending clinics for follow-up care between July and August 2009). These clinics are 
KwaMsane, Madwaleni and Mtubatuba. 
 This study aims to find reasons that encourage or discourage women from testing for 
cervical cancer. These will be obtained through asking questions about cancer 
screening, experiences and knowledge about cervical cancer. The study of this nature 
is important as information obtained will be used to recommend alternatives or 
improvements in the present method of cervical screening service provision and 
promotion. 
 Women (30 years and above) will be asked to participate in the study as they come to 
the MDP clinic. Full Information about this study will be given in your local language 
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and you will be asked to sign an informed consent to participate. Once full informed 
consent is obtained the researcher will then administer the questionnaire using local 
language understood by participants. All data obtained will be kept secured in a 
lockable cabinet until the analysis stage. The questionnaire administration will take 
approximately 10 minutes. 
 There will be no randomization for this study. Participants will be asked to participate 
as they come to the clinic, this will be convenient sampling.  
 No medications will be used in this study as it is not an intervention trial. 
 
Why have you been invited to participate? 
 You are invited to participate in this study to share your experiences, knowledge and 
perceptions of screening for cervical cancer and cervical cancer. According to the 
National cancer screening programme women should start screening for cervical 
cancer from age 30 and above, that is why this study will target women of your age. 
 
What will your responsibilities be? 
 You are asked to give true and honest answers to all questions asked. You will not be 
judged for answers given but where the researcher feels she/he needs to correct 
misconceptions she/he will do so after the interview. 
 
Will you benefit from taking part in this research? 
 There will be no direct personal benefit linked to participation in this study, however, 
information obtained might be used to improve cancer screening services and health 
promotion in the future. 
 
Are there any risks involved in your taking part in this research? 
 No major risks are envisaged through your participation in this study. Some minor 
risks could be spending a longer time than you expected in the clinic. 
 
If you do not agree to take part, what alternatives do you have? 
 Your participation in this study is voluntary, your non-participation will not 
jeopardise any health care you may seek in the future. 
 
Who will have access to your medical records? 
 Information collected will be treated as confidential and protected. All source 
documents will be kept locked in a filing cabinet. For trial participants screening 
numbers will be used. The research nurses collecting data and the researcher will 
have access to the information collected. Once analysed, information will be used in a 
publication or thesis, however, your identity will remain anonymous.   
 
What will happen in the unlikely event of some form of injury occurring as a direct 
result of your taking part in this research study? 
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 Since this is a descriptive study and not an intervention study, no adverse events are 
anticipated, thus issues of insurance cover are not addressed. 
  
Will you be paid to take part in this study and are there any costs involved? 
No, you will not be paid to take part in the study but your transport and meal costs will be 
covered for each study visit. (NB re-imbursement already covered for participants in the 
MDP trial)  There will be no costs involved for you, if you do take part. 
Is there anything else that you should know or do? 
 You can contact the Committee for Human Research of the University of Stellenbosch 
at 021-938 9207 if you have any concerns or complaints that have not been 
adequately addressed by your study doctor. 
 You will receive a copy of this information and consent form for your own records. 
 
Declaration by participant 
By signing below, I …………………………………..…………. agree to take part in a 
research study entitled (Women’s awareness, knowledge and experiences regarding cervical 
cancer and cervical cancer screening in rural KwaZulu-Natal). 
 
I declare that: 
 I have read or had this information and consent form read to me and it is written in 
a language with which I am fluent and comfortable. 
 I have had a chance to ask questions and all my questions have been adequately 
answered. 
 I understand that taking part in this study is voluntary and I have not been 
pressurised to take part. 
 I may choose to leave the study at any time and will not be penalised or prejudiced 
in any way. 
 I may be asked to leave the study before it has finished, if the study doctor or 
researcher feels it is in my best interests, or if I do not follow the study plan, as 
agreed to. 
 
 
Signed at (place) ......................…........…………….. on (date) …………....……….. 2008. 
 
…………………………   ……………………………….. 
Signature of participant   Signature of witness 
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Declaration by investigator 
I (name) ……………………………………………..……… declare that: 
 I explained the information in this document to ………………………………….. 
 I encouraged him/her to ask questions and took adequate time to answer them. 
 I am satisfied that he/she adequately understands all aspects of the research, as 
discussed above. 
 I did/did not use a translator.  (If a translator is used then the translator must sign 
the declaration below. 
 
 
Signed at (place) ......................…........…………….. on (date) …………....……….. 2008 
 
…………………………   ……………………………….. 
Signature of investigator   Signature of witness 
 
Declaration by translator 
 
I (name) ……………………………………………..……… declare that: 
 I assisted the investigator (name) ………………………………………. to explain 
the information in this document to (name of participant) 
……………..…………………………….. using the language medium of IsiZulu. 
 We encouraged him/her to ask questions and took adequate time to answer them. 
 I conveyed a factually correct version of what was related to me. 
 I am satisfied that the participant fully understands the content of this informed 
consent document and has had all his/her questions satisfactorily answered. 
 
Signed at (place) ......................…........…………….. on (date) …………....……….. 2008 
 
…………………………   ……………………………….. 
Signature of translator   Signature of witness 
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Appendix C - Ethical approval: Stellenbosch University 
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Appendix D – Ethical approval: Research development and support 
 
 
02 April 2009                                                             MAILED 
Mrs BH Ndlovu 
Nursing Science 
 
Dear Mrs Ndlovu 
 
"Women's awareness, attitudes and experiences to smear testing and cervical cancer in rural KwaZulu-
Natal" 
 
ETHICS REFERENCE NO: N08/08/206 RE: RATIFICATION 
At a meeting that was held on 01 April 2009, the Committee for Human Research ratified the approval 
of the above project by the Chairperson. 
 
Yours faithfully 
MRS EL ROHLAND 
RESEARCH DEVELOPMENT AND SUPPORT 
Tel: 021 938 9677 / E-mail: elr@sun.ac.za 
Fax: 021 931 3352 
22 November 2010 15:16 
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